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ABSTRACT
The future of diagnostics and therapeutic drugs in biomedicine is nanoparticles.
These nanoparticles come in many different shapes, sizes, and combination of materials.
Magnetic nanoparticles have been studied for many years for use in biomedicine, not
only for their high surface area, but also because of its unique magnetic properties. They
can magnetically interact with their environment, be guided to a specific location, and
manipulated to release energy in the form of heat. To ensure that these magnetic
nanoparticles survive in the circulatory system, they must be modified with materials to
make them colloidally stable in water and shield them from the body’s immune response
to foreign objects.
The purpose of this project is to design and synthesize a ligand for the
modification of iron oxide nanoparticles with three important characteristics: 1) waterdispersable, 2) biologically stable, and 3) functional surface. This was accomplished by
synthesizing specialized heterobifunctional polyethylene oxide (PEO) that has a catechol
on one end to bind strongly to iron oxide nanoparticles and an alkyne on the other end to
provide further functionality. This design allows for easy customization of the particles
surface, using “click chemistry,” with targeting and fluorescent moieties for any desired
application.
The work reported discusses the techniques used for synthesizing a variety of
heterobifunctional PEO via anionic ring opening polymerization of ethylene oxide and
subsequent end group modifications that ultimately led to the design of a universal ligand
for iron oxide nanoparticles, with improved stability in biological environments, that can
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be used in many biomedical applications. These universal magnetic nanoparticles were
modified with different fluorescent dyes for imaging biofilms, carbohydrates for targeting
bacteria, and radiotracers for multifunctional diagnostic probes to demonstrate the
versatility of this surface.
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CHAPTER 1. INTRODUCTION MAGNETIC NANOPARTICLES FOR TARGETED
MAGNETIC HYPERTHERMIA
1.1. ABSTRACT
Nanotechnology provides a unique approach to solving some of the world’s
biggest problems. One of the largest research areas currently utilizing nanotechnology in
the form of nanoparticles, particles smaller than 100 nm, is biomedicine. Typically these
nanoparticles are used as a vessel for carrying therapeutic drugs for treatment or
diagnostic dyes for imaging because of the large surface area available to carry these
agents. Much work has been done into the synthesis of nanoparticles using inorganic,
magnetic materials that adds magnetic component that can be manipulated in a magnetic
field. For biomedicine, they offer a new functionality that can be taken advantage of for
delivery (magnetic targeting), therapy (magnetic hyperthermia), and diagnostics (contrast
agents) that was not available before. Unfortunately, many of these magnetic
nanoparticles are synthesized using hydrophobic ligands that are incompatible for
biomedical applications and require water-soluble coatings to improve biocompatibility.
This chapter will provide background information about the different types of inorganic
materials used in magnetic nanoparticles, surface coatings used to make them more
biocompatible, how their size and surface can affect delivery and treatment, the
importance of polyethylene oxide (PEO) for biological stability of drugs, and how “click
chemistry” has revolutionized drug conjugation.

1

1.2. MAGNETIC HYPERTHERMIA
The application of alternating magnetic fields to magnetic materials, known as
magnetic hyperthermia, was first investigated by Gilchrist et al. in 1957.1 The general
procedure for magnetic hyperthermia involves the accumulation of magnetic
nanoparticles via the local application of a magnetic field or surface functionalization
with targeting ligands that specifically bind to cell or tissue receptors after systemic or
local administration. Once the magnetic nanoparticles (MNPs) are in the desired location,
an alternating magnetic field of specified field and frequency is applied to generate heat
and increase the temperature of the surrounding diseased tissue. Ideally, the tissue is
heated to approximately 42ºC for at least 30 minutes.2 This targeted “fever” results in the
destruction of cancer or other unwanted cells and tissue. Magnetic hyperthermia has
been successively demonstrated in numerous cancerous treatments in vitro and in vivo,
such as melanoma,3 glioma,4 and human colonic adenocarcinoma.5
1.3. INORGANIC MAGNETIC NANOPARTICLES USED IN BIOMEDICAL
APPLICATIONS
Since metal-oxides were synthesized into nanoparticles, they have been of interest
in the medical field for use in imaging and drug delivery due to their response to applied
magnetic fields. Examples of different inorganic nanometer sized particles developed for
magnetic applications are iron platinum,6-10 iron palladium,11 cobalt platinum,12,13 cobalt
oxide,14 and manganese based nanoparticles.15,16 Although these particles exhibit superior
magnetic properties, they are not as biocompatible as iron oxide based nanoparticles
(IONP),17 i.e. magnetite (Fe3O4),18 and maghemite (γ-Fe2O3).19 IONPs have been used for
years in magnetic resonance imaging (MRI) contrast agents to improve medical

2

diagnostics.20,21 There has also been recent interest in the use of these same particles in
magnetic cell separation22,23 and magnetic hyperthermia for cancer therapy.2,24-26
Other substituted ferrites, CoFe2O4,26 MnFe2O4,27 and NiFe2O4

28

are being

studied for their use in contrast agents and magnetic hyperthermia because of their high
specific absorption rate (SAR) and biocompatibility once modified with a stabilizing
layer. Pradhan et al. compared the magnetic heating properties and biocompatibility of
Fe3O4, CoFe2O4, and MnFe2O4 modified with lauric acid. They discovered that Fe3O4 and
MnFe2O4 had the higher SARs, 120 and 97 W g-1 ferrite, respectively. CoFe2O4 not only
had the lowest SAR at 37 W g-1 ferrite, but the percent viability was the lowest for every
concentration studied.29 Buckley et al. has also shown that nickel zinc ferrite
nanoparticles can be used in shape memory polymers for medical stints and intravascular
actuators.30
Noble metals such as gold and silver have also been synthesized into
nanoparticles that have distinct optical (e.g. plasmonic) and surface properties for
biological applications.31 Gold is useful as a tracer and silver nanoparticles are very
strong light absorbers and scatterers.25,32-34 These nanoparticles are used in catalysis and
chemical sensing, as shells for magnetic nanoparticles to improve ligand binding, and in
exploiting magnetic and optical properties.35,36 These properties make them ideal for
biological conjugation and labeling applications using photothermal imaging, dark field
microscopy, and fluorescent microscopy.37
Metal oxide magnetic nanoparticles are synthesized using different methods based
upon the application of the IONP system. One of the most common procedures used to
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create IONPs involves co-precipitation of iron (II) chloride and iron (III) chloride from a
basic solution in water.38,39 This method generally produces MNPs with a charged surface
and polydispersity. More advanced synthetic methods have been developed to produce
size controlled, monodispersed nanoparticles by the decomposition of metal precursors in
high boiling point (~300ºC) solvents and surfactants.15,18 The surfactants that are
generally used are fatty hydrocarbons that produce hydrophobic particles. These
hydrophobic surfaces are unsuitable for the aqueous environment of the body and require
further surface modification.
1.4. NANOPARTICLE SIZE EFFECTS ON MAGNETIC NANOPARTICLES
Literature suggests that Néel relaxation of the magnetic moments, (Figure 2A) has
the most influence on the heating of single domain particles, whereas Brownian losses
(Figure 2B) brought about by particle rotation against viscous forces do not contribute to
frequencies suggested for medical applications; the MNPs must be larger.40

A.

B.

Figure 1.1 (A) Néel relaxation and (B) Brownian motion mechanisms when exposed to
an AC field
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In a recent study comparing the heating rates of 16 commercially available MNPs
systems,41 the Pankhurst group found that the Resovist (Bayer-Schering) and NanomagD-spio100 (MicroMod) particles produced the greatest power generated per mass. Both
systems consist of clusters of 6-12 nm diameter IONPs coated with cyclodextran for a
hydrodynamic diameter of 60-90 nm. Both also had high magnetic crystalline diameters
determined via fitting of superconducting quantum interference device (SQUID)
hysteresis loops. While these high crystalline diameters are perhaps due to single domain
effects, this phenomenon could also indicate close particle clustering, resulting in
behavior analogous to that of multi-domain structures. Such behavior supports the
hypothesis that clustering nanoparticles are a major catalyst in the heating rate and
efficiency in magnetic hyperthermia. Additional research on particle interaction affecting
the heating rate and efficiency in magnetic hyperthermia has been reported.42 Particles
with a small particle interaction radii determined by small angle neutron scattering
(SANS) exhibited heating rates seven times as great as particles with larger radii. The
authors theorized that close interactions could significantly enhance dipole interactions as
well confining heat output to a smaller area.42 Eggeman et al., comparing well-stabilized
monodispersed particles to highly clustered commercially available particles, found that
the clustered particles exhibited significantly greater heating than their well dispersed
counterparts.43 These findings suggest that the composition and size of the particles is
insufficient for predicting particle response to alternating magnetic fields.
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1.5. MEASURING HEATING EFFICIENCY OF MAGNETIC NANOPARTICLES
One way of characterizing magnetic particle-polymer complexes is by calculating
the power generated per mass of magnetic material. The power generated by a solution of
MNPs with the application of an alternating magnetic field can be described as the
volumetric power dissipation, P, in watts per unit volume,44 shown below.
𝑷=

𝝁𝟎 𝝎𝟐 𝝉𝑯𝟐𝟎 𝝌𝟎
𝟐(𝟏 + 𝝎𝝉 𝟐 )

where 𝜇! is the permeability of free space (1.26×10-6 kg m s-2 A-2), 𝜔 is the
frequency of the magnetic field, 𝜏  is the relaxation time, Η! is the magnetic field intensity,
and 𝜒! is the magnetic susceptibility.
Because not every MNPs system is identical, the heating efficiency of particles is
given by the specific absorption rate (SAR) or specific loss power (SLP).45-48
𝑺𝑨𝑹 = 𝑪

𝒎𝒔𝒂𝒎𝒑𝒍𝒆 𝐝𝑻
𝒎𝒊𝒓𝒐𝒏  𝒐𝒙𝒊𝒅𝒆 𝐝𝒕

where 𝐶 is the specific heat capacity of the media (e.g., 4.186 J g-1 °C-1), 𝑚!"#$%&
is the mass of the sample, 𝑚!"#$  !"#$% is the mass of iron oxide determined magnetically,
and 𝑑𝑇/𝑑𝑡 is the slope of the heating curve.
To measure the SAR of a MNP solution, an alternating magnetic field system is
utilized. These consist of a copper induction coil that wraps around the sample, capacitors
to form a resonance circuit, and a power supply. The induction coil is wrapped around the
sample holder that is temperature controlled by recirculating water, Figure 1.2. An
example of a capacitance network, used by Ivkov et al., created an oscillation of ~153
kHz and used a 0-25 kW generator to power it.49 The sample chamber’s magnetic field is
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mapped with a magnetic probe to measure the field produced in the induction coil. An
infrared thermocouple is used to monitor temperature change over time of the magnetic
fluid.40,41,45,46,48,50-52 Studies show that higher heating rates are obtained by decreasing the
polydispersity and “optimizing the size for a given set of conditions, most specifically the
frequency of the AC-field.” 45

Figure 1.2. General schematic of AC calorimeter that can be used to measure SAR.
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Currently, there is one unit magnetic hyperthermia applicator in clinical use
[MFH300F].53 This system uses an alternating magnetic field with a frequency of 100
kHz and variable field strength of 0-18 kA m-1. To measure heating rate in situ, fiber
optic thermocouples were surgically positioned into the prostate, urethra, rectum,
perineum, scrotum and left ear and monitored with software. The temperature could be
read at a constant field strength or even allow the researchers to adjust the field strength
to reach any desired temperature.
Though current MNPs systems used for magnetic hyperthermia studies are
generally polydisperse in size, it is speculated that more monodispersed particles will
create a more efficient therapeutic system.44 While some experimental protocols have
been used to report the heating efficiencies of these materials like SAR, the field lacks a
consistent and accepted manner to characterize the heating efficiency that can be
reproduced throughout the community. For example, the SAR value reported by one
instrument may be different than that reported for the same material by an instrument
operating at a different field and frequency of the first measurement. In addition the SAR
value does not include specifics regarding “size, size distribution, shape and chemical
composition of particles, frequency and amplitude of magnetic field”.46 General
equations describe SAR as the heat capacity of the material multiplied by the change in
temperature over some given time. M. Ma et al. described the equation that uses a mass
weighted mean value of the heat capacity of the particles and solvent.48 Because the SAR
value can be altered for the same sample by merely modifying the field frequency and
strength, the intrinsic loss power (ILP) was developed to better compare between
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experiments by adding field (𝐻) and frequency   (𝑓) to the equation, but only at
frequencies below two megahertz and a polydispersity of 0.1.41
𝑰𝑳𝑷 =

𝑺𝑨𝑹
𝑯𝟐 𝒇

While the ILP offers an alternative to reporting SAR, it does not resolve the issues
related to difference in instrumentation. For example, the ILP normalization is only
effective in the linear region according to Eggemen et al.43 They found that the size,
composition, and shape are not enough to predict the effects they have on heating in an
alternating magnetic field.
1.6. PARTICLE MODIFICATION
Nanoparticle systems used for targeted drug delivery have historically been
liposomes, polymer-drug conjugates, and micelles that deliver a drug encapsulated into
the core of the nanoparticle. Liposomes are made up of a phospholipid bilayer that
comprise of lipids that have a fatty hydrocarbon tail and a hydrophilic head group; these
separate an aqueous internal compartment from an aqueous bulk. Micelles are comprised
of a lipid monolayer that has a fatty core and a charged hydrophilic surface.
Surface modification of nanoparticles is critical to improving stability,
biocompatibility, and success in targeted magnetic hyperthermia, which is discussed later
in this review. The nanoparticle complexes described here are a core-shell structure, in
which iron oxide is the core and the shell is comprised of polymeric coatings. Examples
of these core-shell complexes can be found in Table 1. MNPs have been modified with a
variety of ligands using different synthetic routes. One commonly used method for
surface coating is the physical adsorption of material onto the surface of the particle.
9

Another such method to coat MNP surfaces also involves covalently or electrostatically
bonding a polymer to the particle surface. Electrostatically binding of a polymer to
modify IONPs has been reported with different polymer ligands using end and side chain
functional groups such as carboxylates,54 alcohols,55 amines,56 and phosphates.57,58 For
example, dextran has been shown to adsorb to the surface of IONP to create a dispersible
complex in a biological system.59 Dextran has been used to modify coprecipitation MNPs
for biological systems currently used in MRI contrast agents.20 Unfortunately, some of
these binding groups can be displaced by other anions such as phosphates and silicates.60
Once in contact with biological fluids, however, this displacement of the polymer coating
on the surface of the magnetic nanoparticles can lead to IONP instability and aggregate
formation. The advantage of chemical adsorption over physical adsorption is strength of
adhesion to the particle. The heat of adsorption is much higher for a chemical bond (-40
to -1000 kJ/mol) than physical interaction (-10 to -40 kJ/mol) of a molecule onto a
surface.61 A binding group that shows great promise for binding biologically inert ligands
are catechol derived anchor groups.62-64 Gu et al. has demonstrated that oleic acid and
oleic amine on the surface of magnetite can be displaced with dopamine derivatives that
bind tightly to iron oxide surfaces.65 Amstad et al. used dopamine as an anchor for
adsorption of PEG onto the surface of magnetite and showed stability of particles in
physiological conditions.66
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Table 1. Representative schematics of existing magnetic nanoparticle complexes

Particle Complex

Description

Magnetic nanoparticle coated with hydrophilic polymer
ligand7,57,67-69

Multiple magnetic nanoparticles encapsulated in crosslinked polymer matrix70,71

Single magnetic nanoparticle with copolymer ligands;
PEO/PLA, PEO/PGMA72,73

Ligands with hydrophobic head and hydrophilic tail to
encapsulate particle25,74

Nobel metal coated magnetic nanoparticle31,35,36

Controlled clustering of nanoparticles, and then coated
with polymer shell75
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Biologically inert polymers have been used to modify IONPs for magnetic
hyperthermia, which is advantageous for controlling the particles size and functionality
that permits multiple applications. Polyethylene glycol (PEG) is one such polymer being
explored for use biological particle systems. Because of its solubility in water, low
immunogenity, and fast renal clearance, PEG is ideal for biomedical applications.76 Many
multifunctional PEG ligands have been synthesized, some of which are commercially
available, for modifying MNPs.
Block copolymers have been exploited for altering solubility and thermal
properties for entrapment and controlled release of drugs, a concept also applied to the
encapsulation of MNPs. Triblock copolymers of polyethylene glycol and polypropylene
oxide (PPO), commonly known as a pluronic, have been used in multiple applications (i.e.
detergency, emulsification and drug delivery systems).77 This amphiphilic polymer has
been utilized to create a polymer shell that is biocompatible and can be modified for
targeting purposes. Pluronics have also been studied for the use in temperature-controlled
release of drugs; when the polymer is above its critical micelle temperature, the polymer
collapses on itself to contain the drug. Once the MNPs are accumulated in the diseased
tissue, the temperature is decreased to extend the ligands and release the drug.72,73
Another polymer system of interest for the temperature-controlled release of drugs is
random block copolymer composed of poly(N-isopropylacrylamide) (pNIPAAm) with
hydrophilic monomers. These thermo-sensitive block copolymer have a lower critical
solution temperature (LCST) in which the polymer, above the LCST converts to a coiled
formation as opposed to extended chain formation.78 Meyer et al. have combined
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PNIPAAm and PEG as a copolymer to encapsulate MNPs and drugs simultaneously.
When these particles are subjected to an AC field, temperatures higher than LCST of the
PNIAAm are achieved, causing the polymer to coil and force the encapsulated drug into
the surrounding tumor.79
1.7. SIZE AND SURFACE CHARGE EFFECTS ON STABILITY
Designing a stable MNPs system requires a balance between repulsive and
attractive forces within a colloidal system. According to a modified Derjaguin-LandauVerwey-Overbeek (DLVO) theory, shown in Figure 1, these forces include van der
Waals, electrostatic repulsion, steric repulsion, and magnetic attraction forces that
mediate the stability of an MNPs system.79 Magnetic interactions for superparamagnetic
nanoparticles, ideally should be non-existent. Achieving a narrow size distribution of
particles that have no net magnetic moment is difficult and will require an increase in the
repulsion forces to decrease agglomeration due to magnetic interactions.80

Figure 1.3. The interaction potential between magnetic nanoparticles can be determined
by adding the potential energies of the particles as a function of their distance.
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By calculating the potentials for the interaction between two particles in solution,
it is possible to infer the effects of various parameters (i.e. core particle size, degree of
coverage by stabilizing layer, molecular weight of the stabilizing polymer, solvent
conditions, etc.). For example, the radius of the core of MNPs is critical for the colloidal
stability of a system; indeed small portions (<1%) of the population of a polydisperse
system may be responsible for agglomeration.67
1.8. MOLECULAR WEIGHT AND SURFACE CHARGE EFFECTS ON STABILITY
Surface modification, using methods described previously, alters the MNPs in
order to: i) reduce the immune response of the body; ii) enable the homogeneous
suspension of the nanoparticles in physiological solutions; and iii) provide a stabilizing
layer that prevents particle agglomeration. For example, Ditsch et al. coated 7.5nm
diameter (polydispersity of 0.26) magnetite nanoparticles with block copolymers of
sodium styrene sulfonate, sodium vinyl sulfonate and acrylic acid. It was discovered that
at low molecular weights, e.g. <15 kDa, steric repulsion was not great enough such that
particle clustering may occur. Steric repulsion was enhanced when the PEG molecular
weight increased which resulted into a suspension of dispersed particles. However, if
molecular weight is further increased, e.g. 30kDa, polymer chains begin to entangle and
clustering would again occur in the system caused by entanglements of neighboring
particles’ brushes and thus bring the particles together.75
Both the molecular weight and the structure of the surfactant affect particle
stability,81 particularly in copolymers with hydrophobic and hydrophilic blocks, like
PEG-PPO block copolymers. PEG is a liner polyether comprised of a repeat unit of two
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methylene groups and an oxygen, which gives it hydrophilic properties. PPO has a very
similar structure, but has a branched methyl group off of the methylene groups in the
chain that makes it hydrophobic.

The molecular weight necessary for minimum

clustering will shift with a ratio change between the hydrophilic and hydrophobic
segments in the polymer chain. If the hydrophilic segment is larger than the hydrophobic,
an increase in the total molecular weight of polymer chains is required to minimize
clustering.75
When modifying nanoparticles with a polymer, the overall particle size can
increase significantly, affecting the functionality of the system. Compared to the
autonomous magnetic core, the magnetic field strength of coated IONPs decreases by a
small percentage. For example, in the development of MRI contrast agents, Tong et al.
used different molecular weight IONP polymer coatings to demonstrate diverse T2
relaxivity. Using 5 and 14nm magnetite nanoparticles coated with PEG with molecular
weights of 550, 750, 1000, 2000, and 5000 g mol-1, respectively, they found that the
particle system with the highest T2 relaxivity–385 ± 39 s-1mM-1–was the 14 nm diameter
particle with 1000 g mol-1 coating. However, the indeterminate relationship between
polymer molecular weight and T2 relaxation rate suggests the necessity of additional
study.82
It should be noted that for each size of magnetite particle, a sufficient steric or
electrostatic stabilizing layer is necessary to maintain good colloidal stability.67
Electrostatic effects are a product of the surface chemistry83 of the particle as well as the
medium in which it is dispersed84. Relying on electrostatic repulsion alone could be a
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poor choice, as the high ionic strength of the body would result in weak colloidal stability.
This insufficient repulsive energy is due to ionic screening of the electric double layer
around the particle. Wiogo et al. completed size and zeta potential studies on magnetic
nanoparticles with carboxylic acid on the surface in water, phosphate-buffered solution
(PBS), and cell culture media (RPMI-1640) to show how the ionic nature of the body can
cause suppression of the electrostatic double layer on a nanoparticle used for biomedical
applications.85 They found that in water, the zeta potential was -32+/- 5 mV and there
was no significant size change after 16hrs. The same particles in PBS and cell culture
media showed a ~10 mV decrease in zeta potential and a shift in the size distribution to
larger size agglomerates.
1.9. IMPORTANCE OF POLYETHYLENE GLYCOL IN THERAPEUTICS
Polyethylene glycol (PEG) has been a FDA approved for use in a variety of
cosmetics, pharmaceuticals, and even an additive in food.86 Due to its structure, it shows
low toxicity and has renal clearance, <30 kDa.87 One of the initial applications of PEG
was to overcome issues had with modifying polypetides with liposomes for drug
delivery.88 The first PEGylation, a term describing the modification of small molecules
with PEG, was done by Abuchowski et al. in 1976. Their group covalently attached
monomethoxy terminated PEG, 1900 and 5000 g mol-1, to bovine liver catalase and
found that it enhanced the circulation time in the blood of mice with no negative immune
response to the modified enzymes.89 PEGylation is not only limited to enzymes, but has
also been used to modify proteins to give it desirable drug delivery properties. A study on
PEG in solution with proteins of similar molecular weight has found that the interaction
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of water molecules with the polymer increases the size, protecting the proteins from
immediate renal clearance and enzyme degradation.90
Taking advantage of the unique biological properties of PEG, it can be linked to
therapeutic agents to improve solubility, increase circulation in the body and decrease
toxicity that are inherit in many small molecule drugs, including antitumor agents.91.
Unfortunately, linking therapeutic agents to monofunctional PEG is limited in its
efficiency because it can only rely on passive targeting to deliver the drug. Passive
targeting takes advantage of irregular vascular structures in tumors to deliver the drug.
Adding active targeting agents to drug complexes is needed to improve delivery
efficiency. Active targeting requires a compound that will bind to over-expressed
receptors found in tumors.92 One example of an active targeting compound is folic acid;
many epithelial cancer cells, ie. ovary, kidney, colon, and lung, over-express folate
receptors that have a high affinity for folic acid.93 Synthesizing PEG that can carry a drug
and target specific receptors was the next step in drug delivery. In 2007, a group from
Rutgers University reported the modification of a bis-carboxyl PEG modified with
doxorubicin and sialic acid that showed an increase in anticancer activity and
bioavailability.94 Improvement of therapeutic efficiency by attaching a targeting and drug
to PEG was a huge advancement, but is limited by the extremely low drug loading that is
inherent with a chain that can have a maximum of two functionalities. This has brought
about the advancement of branched and multi-armed PEGs to provide multiple functional
groups to increase the loading of therapeutic agents.95
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The use of polymers for the advancement of drug delivery naturally progressed
into the development of polymeric nanoparticles for the same application. Polymeric
nanoparticles, made up of conjugated96 and amphiphilic block copolymers,97 provide a
large surface area and increased functionality that can be conjugated with a variety of
drugs and targeting moieties.
1.10. “CLICK CHEMSTRY”
In a review by Kolb et al., they describe the foundation of the approach to “click
chemistry” is to join small units together using selective and modular ‘blocks’ that can
work in small and large scale applications.98 Using “click chemistry” as the approach for
combining two molecules together is ideal for optimizing drug development and
conjugation.99Nucleophilic ring opening reactions, carbonyl chemistry, and cycloaddition
are all examples of synthetic routes that are under the umbrella of “click chemistry,” as
defined by Sharpless.98,100
The reaction that is almost synonymous with “click chemistry” is the 1,3-dipolar
cycloaddition of alkynes and azides yielding an triazole, developed by Huisgen.100
Alkyne and azide functional groups are extremely stable in many synthetic conditions.101
Unfortunately, the reaction requires heat and creates a product of 1,4 and 1,5
regioisomers, making it difficult to purify.101 That was true until copper (I), created insitu
using a reducing agent, was used to catalyze the reaction in water to yield 1,4disubstituted 1,2,3-triazoles (>95% yield), an example is shown in Figure 1.3.102
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Figure 1.4. Schematic of a 1,3-dipolar cycloaddition of alkyne and azide yielding a
triazole.
The mild reaction conditions of the copper catalyzed reaction of an alkyne and
azide make it an ideal synthetic route for attaching biomolecules to each other, also
referred to as bioconjugation. The triazole linkers are ideal for bioconjugation because
they are soluble and stable in water as well as the harsh biological environments.103
Cowpea mosaic virus (CPMV), a scaffold commonly used for testing bioconjugations,
was modified with an alkyne and was tagged with an azide modified fluorescein, with a
100% efficiency.104 DNA bioconjugation can be quite difficult and inefficient because it
requires aqueous conditions. Seo et al. was able to tag a strand of DNA, for sequencing
studies, modified with an alkyne and with a fluorophore modified with an azide, with a
product yield of 91%.105
These same reactions can be used to synthesize more efficient and specialized
bioconjugated polymers for drug targeting and delivery. One research group used treated
PDMS (hydrophobic) modified with an azide on both ends to attach PEG (hydrophilic)
modified with an alkyne to produce a block copolymer that was used to create polymeric
vesicles to carry hydrophobic drugs.106 Cheng et al. synthesized a heterobifunctional PEG
with an alcohol on one end and bromine on the other. The bromine terminus was then
reacted with sodium azide, via a substitution reaction, to yield an azide terminus. Then
using “click” chemistry, the azide-PEG was attached to a tri-alkyne to produce a three
19

arm PEG that provides three functionalities per macromolecule to increase drug
loading.107 Nanoparticles have also been synthesized to have either an alkyne or azide
surface that can be easily modified with targeting agents (ie. folate)108,109 and dyes(ie.
fluorescein)110 equipped with their respective counter functionality. 111-113
1.11. OVERVIEW
The following chapters will discuss the synthesis of heterobifunctional PEO for
stabilizing magnetic nanoparticles for biological therapeutic and diagnostic applications.
It will begin with the synthesis of a library of heterobifunctional PEO that were
synthesized by the anionic ring opening polymerization of ethylene oxide using a variety
of initiators that can produces thiol, azide, amine, alcohol, vinyl, and trivinyl end groups.
Chapter 2 will also include different end group modification techniques important for
creating functionalities that can be utilized for different applications. Chapter 3 will
involve modifying magnetic nanoparticles with specialized heterobifunctional PEO that
was synthesized using techniques in Chapter 2. These materials have a surface that can be
built upon with diagnostic dyes and targeting moieties for biological applications.
Chapter 4 builds upon the same scaffold that was developed in Chapter 3, but utilizes
multiple binding groups to enhance biological stability while still maintaining
functionality. Finally, the document will conclude with a discussion on how the design of
these particles is not limited to just magnetic hyperthermia for the treatment of cancer,
but that these particles can be used as an alternative to antibiotics, imaging in biofilms
and a probe for emerging medical diagnostics.
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CHAPTER 2.SYNTHETIC TECHNIQUES USED TO PRODUCE
HETEROBIFUNCTIONAL POLYETHYLNE OXIDE OLIGOMERS
2.1. ABSTRACT
Polyethylene oxide (PEO) oligomers have become a desirable material in
pharmaceutical and biomedical applications. The inert backbone in PEO provides a
water-soluble platform that can be easily modified and survive in harsh biological
environments.88 Through various initiators and end group modifications, an assortment of
heterobifunctional PEO can be synthesized and customized for any specialized
application. This chapter discusses the synthesis and characterization of different
heterobifunctional PEO for biological applications.
2.2. INTRODUCTION
Polyethylene glycol (PEG), also referred to as polyoxyethylene (POE) and
polyethylene oxide (PEO), is a “linear or branched polyether often terminated with
hydroxyl groups that are derived from neutralization of the terminal ether repeated unit in
the chain.”114 PEG is generally used when describing lower molecular weight polyethers
(<10000 g mol-1) and PEO describes higher molecular weights (>10000 g mol-1).115 The
repeating units are relatively unreactive which allows for modification of the end groups
without affecting the chain integrity. PEO is also soluble in water and many organic
solvents, which allows for a variety of routes in chemical modification of its end
groups.54 Because of its solubility in water and capability of modification, PEO is ideal
for biomedical applications; it has low immunogenity, renal clearance in vivo, and is not
biodegradable.76
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Creating a facile method for synthesis of heterobifunctional polyethylene oxide
(PEO) is important for the functionalization of nanoparticles, which requires a strong
binding group and then still have an end group that can be easily tailored to give a
specific functionality. This research is vital in the successful integration of a material into
biological environments and have the functionality to complete a task, ie targeting a
specific site or fluorescent imaging. Using different initiators and end group
modifications, a variety of heterobifunctionality can be customized for any application.
There are two ways of synthesizing heterobifunctional PEO. One method involves
the partial derivatization of polyethylene glycol diols, Figure 2.1, and then statistically
collecting the desired heterobifunctional oligomer. This method is time consuming and
extremely inefficient giving very low yields.
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Figure 2.1. Partial derivatization of diols of polyethylene glycol to create
heterobifunctionality.

The second method to creating heterobifunctional PEO is to initiate the
polymerization of ethylene oxide (EO) using a functional initiator and, once propagation
is complete, terminate with functional group as shown in Figure 2.2.116-119 Creating
heterobifunctional PEO using this route generally has high yields and low
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polydispersity.114 Because these reactions are living in nature, it is important to keep
water out of the reaction to avoid the formation of PEO diols that can reduce the targeted
molecular weight.76
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Figure 2.2. Anionic ring opening polymerization using an initiator with X functionality
and then terminating with a functionality of Y.
The hydroxyl terminus is a great platform for synthesizing complex
heterobifunctional end groups. The ease of hydroxyl modification allows for the
conjugation of biomolecules by first modify the end group with carboxylic acid and then
subsequently creating a succinimidyl ether intermediate120 that can easily react with
amines of many bioconjugates.121,122 The purpose of this chapter is to show different
techniques used to synthesize specialized heterobifunctional PEO. A variety of anionic
initiators and end group modifications that were used to create the desired
heterobifunctionality are described in detail.
2.3. MATERIALS AND CHARACTERIZATION
2.3.1 Materials
Tetrahydrofuran (THF; B.D.H. ACS grade) was purified by reflux over sodium
metal (Aldrich Chemistry; sodium lump in kerosene 99%) and benzophenone.
Naphthalene (Aldrich Chemistry ≥99%) was purified by sublimation at 60 °C under
vacuum. Bromophenol blue (Sigma Aldrich), hydrochloric acid (HCl; J.T. Baker, 1N
volumetric solution), acetic acid (BDH, glacial ACS/USD/FCC), ethylene oxide (EO;
Aldrich Chemistry), allyl alcohol (Sigma Aldrich, ≥99%), triisobutylaluminum (Aldrich

23

Chemistry, 25% w/w solution in toluene), tetrabutylammonium azide (Aldrich
Chemistry), dichloromethane (DCM; EMD Millipore Chemicals, HPLC grade), diethyl
ether (DEE; Macron Chemicals), toluene (BDH), 3-chloropropyltrichlorosilane, (Gelest,
Inc.), vinylmagnesium bromide solution (Aldrich Chemistry, 1.0M in THF), ammonium
chloride (Fisher Scientific, Certified ACS, Crystalline), magnesium sulfate (Mallinckrodt
Chemicals, anhydrous powder), sodium chloride (Fisher Scientific, Certified ACS,
Crystalline), sodium iodide (Sigma Aldrich, ACS reagent, ≥99.5%), sodium bicarbonate
(J.T. Baker, anhydrous powder), hexamethylphosphoramide (HMPA; Aldrich Chemistry,
99%),

acetone

(Fisher

Scientific,

Certified

ACS),

(2-(tetrahydro-2H-pyran-2-

yloxy)ethanol (THP; Aldrich Chemistry, purum ≥98% (GC)), chloroform-D (CDCl3;
D,99.8%, Cambridge Isotope Laboratories Inc.), potassium bis(trimethylsilyl)amide
solution (1M THF, Aldrich), and tert-butyl mercaptan (Aldrich Chemistry, 99%), 4(dimethylamino) pyridine (DMAP; Fluka Analytical), N,N’-dicyclohexyl carbodiimide
(DCC; Thermo Scientific), 1-((3-dimethylaminopropyl)-3-ethylcarbodiimide (EDC; Alfa
Aesar, 98%), N-hydroxysuccinimide (NHS; Acros Organics 98+%), propargyl bromide
solution

(80%

in

toluene;

Fluka),

sodium

hydride

(NaH;

Aldrich),

dimethylformamide(DMF; 99.8%, Extra Dry over molecular sieves; Sigma Aldrich),
methanol (absolute ACS reagent grade; Ricca Chemical Company), methacryol chloride
(Fluka Analytical, ≥97.0%, GC, Contains ~0.02% 2,6-di-tert-butyl-4-methylphenol as
stabilizer), and Spectrum Spectra/Por® molecular porous membrane tubing, MWCO of
1K, 12K-14K, and 50K g mol-1 was used as received.
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2.3.2. Potassium naphthalenide preparation
Potassium naphthalenide was prepared in the follow way for all reactions.57 To a
250 mL Erlenmeyer flask, 20g of naphthalene was put under vacuum at 60 °C until all
naphthalene was sublimed onto the inside walls of the flask. The sublimed naphthalene
(14.1 g, 0.11 mol) was then charged to a flame dried, 250 mL round bottom flask
containing a stir bar. After submitted to a heavy purge of nitrogen, 100 mL of THF was
added via syringe. Once naphthalene was completely dissolved, 3.96 g (0.10 mol) of
potassium were added. The reaction was mixed for 12 hours at room temperature in
darkness. The concentration of the solution was determined by titration, using 1 M HCl
solution and bromophenol blue as an indicator, observing a color change from a deep
blue to yellow.
2.3.3. Characterization Techniques
NMR spectroscopy was conducted using a Jeol ECX-300. Polymer samples were
prepared by dissolving 50mg in 1 mL of deuterated chloroform and transferred into a
5mm economy, 7", NMR sample tube via glass pipet. Each sample was analyzed using
64 scans for 1HNMR and 20000 scans for 13CNMR at 20 °C. The NMR was controlled
by Delta NMR Processing and Control Software (v 4.3.6, Windows_NT). The spectra
were analyzed with Delta NMR Processing and Control Software (v 5.0.1, Darwin-x86).
Fourier transform infrared spectroscopy (FTIR) using a Nicolet 6700 FTIR
spectrometer. Spectra were acquired using attenuated total reflectance (ATR) on a
diamond plate in air at room temperature. The wavelength recorded was from 5504500cm-1.
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High-resolution transmission electron microscopy (TEM) images were acquired at
an accelerating voltage of 300 kV on a Hitachi H-9500. TEM samples were prepared by
dropping diluted hexane solutions onto a copper grid with carbon film. The mean size
was acquired by averaging the diameter of 181 particles using FoveaPro image analysis
software.
Photoluminescence (PL) spectra were collected using a Horiba Jobin-Yvon
MicroHR spectrometer.
Thermogravimetric analysis (TGA) was accomplished using a Hi-Res TGA 2950
thermogravimetric analyzer from TA Instruments. Experiments were controlled via
Thermal Advantage Instrument Control Software (v 1.3.0.205) and thermograms were
analyzed using TA Universal Analysis 2000 (v 3.9A, build 3.9.0.9). All samples where
run with TA Instruments' platinum sample pans, 100 µL. The particles were exposed to
nitrogen for 20 minutes, followed by a ramp to 100 ℃ at a rate of 20 °C min-1, held
isothermally for 60 minutes, and then ramped to 800℃ at a rate of 20 °C min-1.
Dynamic Light Scattering (DLS) and Zeta Potential measurements were used to
measure hydrodynamic diameter and surface charge of particles, respectively, using a
Malvern Zetasizer Nano ZS (Model:ZEN3600). Measurements were controlled and
analyzed with Dispersion Technology Software (DTS) (v. 5.10). Size measurements and
zeta potential measurements for water-dispersed particles were done in a “Size & Zeta”
folded capillary cell(DTS1060).
Gel permeation chromatography (GPC) was accomplished using a Waters Breeze
system equipped with a UV/VIS and RI detector. Detection was done by differential
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refractometer at 33 °C. Chloroform was the mobile phase at 1 mL min-1 and the injection
volume per sample was at 50µL using an autosampler. All standards were prepared at 0.5
mg mL-1. All samples had concentrations of 1 mg mL-1 in chloroform and filtered with
0.2 µm Teflon membrane filters. The column used was a Water Styragel HR column –
5E(effective MW range 2K to 4E6).
2.4. ANIONIC RING OPENING POLYMERIZATION OF ETHYLENE OXIDE
USING TERT-BUTYL MERCAPTAN
2.4.1 Experimental
Ethylene oxide, 7.76 g (0.176 mol), was distilled into a 300 mL stainless steel
Parr Reactor cooled to -40℃ using an acetone dry ice bath, followed by the addition of
100 mL of THF. In a separate 50 mL flame dried, round bottom flask with stir bar and
under nitrogen purge, 0.7 mL (6.21mmol) of t-butyl mercaptan was dissolved in 5 mL of
THF. Next, 4.14 mL of a potassium naphthalenide solution (1.35 M) was added via
syringe and stirred for 15 minutes. A white precipitate formed to indicate the formation
of thiolates. The initiator solution was then charged to the reactor via syringe, and
followed by 50 mL of THF. The reactor was brought to room temperature and reacted for
48 hours. Polymerization was terminated with 1.47 mL of 2.5 M acetic acid solution in
THF. The reactor was then purged with nitrogen for 1hr. Solvent was removed by rotary
evaporation, and the product was dissolved in 200 mL of chloroform. The solution was
then washed with 150 mL of deionized water. The organic layer was then concentrated
down and precipitated using cold DEE and the polymer was retrieved by filtration. The
remaining polymer was dried in vacuum oven at 25 °C (yield: 6.38g). 1HNMR (300 MHz,
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CDCl3, δ in ppm): 3.61 (m, (CH2-CH2-O)n), 2.54 (t, CH2-S-C-(CH3)3), 2.43 (s, CH2-CH2OH), 1.29 (s, -CH2-S-C-(CH3)3.
2.4.2. Results and Discussion
Polyethylene oxide is typically synthesized by nucleophilic attack on the
methylene group using an anionic initiator. In this case, the anionic initiator was created
using potassium naphthalenide and tert-butyl mercaptan, shown in Figure 2.3, the thiolate
formation was confirmed by precipitation.118 After the initiator was added to the
monomer solution, the reaction was preformed under room temperature at 40 psi. After
48 hours, the change in pressure dropped about 7 psi, indicating that nearly all of the
ethylene oxide has been consumed. Acetic acid was used to protonate and terminate the
living polymer. The polymer solution was then washed with water to remove any acid
and then precipitated multiple times to remove any unreacted initiator.
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Figure 2.3. Anionic ring opening polymerization of ethylene oxide using tert-butyl
mercaptan

End group characterization and molecular weight of the polymer was then
analyzed using 1HNMR. As seen in the spectrum in Figure 2.2, the two hydrogens of the
methylene group adjacent to the thiol were observed as a triplet at 2.71 ppm. The three
methyl groups in the protected group of the thiol have a chemical shit at 1.29 ppm (9H).
There is also the characteristic shift at 3.61 ppm for the side-by-side methylene groups in
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the backbone of polyethylene oxide. Comparing the relative integrations of the methylene
and the protecting group of the tert-butyl mercaptan to the integration of the methylene
groups in the polyethylene oxide, the number average molecular weight was calculated to
be ~1690 g mol-1. The target molecular weight of 2500 g mol-1 was not met possibly due
to sample preparation and polymerization execution. Although extreme caution was used
to keep all reactants and glassware dry, oxygen may have been present which could cause
premature chain termination, thus decreasing the overall molecular weight. There is also
a good possibility that the reaction was not given sufficient time to propagate, leaving
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Figure 2.4. 1HNMR spectra of tert-butyl-thiol initieated PEO
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2.5. ANIONIC RING OPENING POLYMERIZATION OF ETHYLENE OXIDE
USING ALLYL ALCOHOL
2.5.1 Experimental
Ethylene oxide, 9.12 g (0.207 mol), was distilled into 300 mL stainless steel Parr
Reactor cooled to -40 °C using an acetone dry ice bath, followed by the addition of 100
mL of THF. In a separate 50 mL flame dried, round bottom flask with stir bar and under
nitrogen purge, 0.22 mL (3.23 mmol) of allyl alcohol was dissolved in 10 mL of THF.
Via syringe, 3.26 mL of potassium naphthalenide solution (0.9 M) was added and stirred
for 10 minutes. The initiator solution was then charged to the reactor via syringe, and
followed by 50 mL of THF. The reactor was brought to room temperature and reacted for
36 hours. Polymerization was terminated with 1.30 mL of 2.5 M acetic acid solution in
THF. The reactor was then purged with nitrogen for 1 hour. Solvent was then removed by
rotary evaporation, and the product was dissolved in 200 mL of chloroform. The solution
was then washed with 150 mL of deionized water. The organic layer was then
concentrated down and precipitated using cold DEE and the polymer was retrieved by
filtration. The remaining polymer was dried in vacuum oven at 25 °C (yield: 5.855 g).
1

HNMR (300 MHz, CDCl3, δ in ppm): 3.617 (m, (CH2-CH2-O)n), 5.219 (m, CH2=CH-

CH2-), 5.880(m, CH2=CH-CH2-), 4.00, (d, CH2=CH-CH2-), 2.611 (s, CH2-CH2-OH).
2.5.2. Results and Discussion
The synthesis of an allyl alcohol initiated PEO, shown in Figure 2.5,123 with a
target molecular weight of 2400 g mol-1 was accomplished by first creating an alkoxide
by putting it into solution with a slight deficiency of potassium naphthalenide. The
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reaction was done under 57 psi at a temperature of 24 °C and after 3 days, the pressure
dropped to 50 psi indicating the polymerization of ethylene oxide and yielded 5.8 g of
PEO. The allyl end can act as an intermediate that can be modified with an amine or
carboxylic acid using thiolated compounds through radical addition.76
O
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Figure 2.5. Anionic ring opening polymerization of ethylene oxide using allyl alcohol as
an initiator.
Proton NMR was used to determine if the desired heterobifunctionality was
accomplished. The hydrogens of the alkene were found at 5.88 (2H) and 5.23 ppm (1H).
The adjacent methylene had a chemical shift of 4.00 ppm (2H) and the methylene shift of
the PEO backbone was at 3.62 ppm (284H). The number average molecular weight was
determined to be 3200 g mol-1 by comparing the integration of the chemical shifts of the
alkene end group to the methylene hydrogen shifts of the PEO backbone. The number
average molecular weight of the polymer was also determined by GPC, compared to PEO
standards, to be 2138 g mol-1 with a PDI of 2.04.
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Figure 2.6. Anionic ring opening polymerization of ethylene oxide using allyl alcohol
2.6. ANIONIC RING OPENING POLYMERIZATION OF ETHYLENE OXIDE
USING TETRABUTYLAMMONIUM AZIDE
2.6.1. Experimental
Using a modified procedure from Gervais et al.,117 ethylene oxide, 15.2 g (0.345
mol), was distilled into 300 mL stainless steel Parr Reactor cooled to -40℃ using an
acetone dry ice bath, followed by 100 mL of toluene. In a flamed dried 50 mL round
bottom flask, 1.0 g (3.52 mmol) of tetrabutylammonium azide was dissolved in 15 mL of
toluene and added to reactor. Triisobutylaluminum, 7.60 mL (7.04 mmol), was added via
syringe and an increase in temperature was observed. The reactor was then brought to
room temperature and reacted for 24 hours. The reactor was then purged with nitrogen
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for 1 hour to remove unreacted monomer. The solution was vacuum filtered and the
solvent was then removed by rotary evaporation, and dissolved in 200 mL of toluene. The
resulting solution was then heated to 50 °C for 1 hour and then cooled to room
temperature to precipitate the polymer to remove any unreacted tetrabutylammonium
azide. The toluene was then removed by rotary evaporation and the product was
dissolved in DCM and precipitated with cold DEE. The remaining polymer, 6.825 g, was
dried in a vacuum oven at 25℃ and characterized by 1HNMR.
2.6.2. Results and Discussion
Synthesis of a heterobifunctional PEO with an azide has been done using end
group modification, usually through a mesylated hydroxyl group that can be substituted
with sodium azide.123 Labbé et al. has done work on polymerizing oxiranes using
tetrabutylammonium bromide and triisobutylaluminum.124 The bromine terminus allowed
for substitution with sodium azide to produce an azido end group.125 This approach
allowed for control of molecular weight and required fewer reactions to get desired
functionality. Gervais et al. built upon the aforementioned work by using a
tetrabutylammonium azide and triisobutylaluminum catalyst to directly polymerize
ethylene oxide and propylene oxide with an azide.117.
The direct synthesis of an azido-terminated PEO, Figure 2.7, was accomplished
with coordination polymerization using a ratio 1:2 of tetrabutylammonium azide and
triisobutylaluminum catalyst, respectively, to target a molecular weight of 6000 g mol-1.
The reaction was done for 24 hours at room temperature, where a decrease in pressure of
about 10 psi was observed.
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Figure 2.7. Coordination ring opening polymerization using tetrabutylammonium azide
and triisobutylaluminum catalyst.
The molecular weight was determined by GPC, against polystyrene standards, to
be 10188 g mol-1 with a PDI of 1.61. Proton and carbon NMR were used to confirm the
azido-terminated PEO. The large peak at 3.64 ppm was the familiar methylene shift for
PEO. Unfortunately, finding any indication of the presence of the azide was difficult to
determine with 1HNMR, Figure 2.8. Via

13

CNMR, Figure 2.9,the carbon from the

methylene peak adjacent to the azide, has a chemical shift at 61.89 ppm. To make sure
that the shift is not part of the noise of the spectrum, contact ATR was used to confirm
the presence of an azide. In Figure 2.10, the characteristic antisymmetric stretch of the
azide appears at 2100 cm-1 and the antisymmetric stretch of the ether in the polyethylene
oxide appears at 1111 cm-1.126
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Figure 2.8. HNMR of anionic ring opening polymerization of ethylene oxide using
tetrabutylammonium azide and triisobutylaluminum catalyst.
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40.0

Figure 2.10. FTIR spectra of anionic ring opening polymerization of ethylene oxide
using tetrabutylammonium azide and triisobutylaluminum catalyst.
2.7. ANIONIC RING OPENING POLYMERIZATION OF ETHYLENE OXIDE
USING HYDROXPROPYLTRIVINYLSILANE (HPTVS) AS INITIATOR
2.7.1. Experimental
2.7.1.1 Synthesis of 3-chloropropyltrivinylsilane
A flame dried, 500 mL round bottom flask equipped with a stir bar and purged
with nitrogen was charged with 25 g (0.112 mol) of 3-chloropropyltrichlorosilane and
brought to 0 °C using a sodium chloride ice bath. A 1 M solution in THF of
vinylmagnesium bromide (353.81 mL, 0.336 mol) was slowly cannulated into the round
bottom flask. The reaction was then brought to room temperature and reacted for 24
hours. To purify, the solution was then diluted with DCM and washed with an aqueous
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ammonium chloride solution followed by three washes with a sodium chloride solution.
Magnesium sulfate was then added to the organic layer to remove any residual water and
them vacuum filtered. The filtrate was then reduced down using vacuum filtration and the
product was distilled at 100 °C at 0.8 torr. Yield (15.69g) 1HNMR (300 MHz, CDCl3, δ
in ppm): 0.841 (m, Si-CH2-CH2-CH2-Cl), 1.825 (m, Si-CH2-CH2-CH2-Cl), 3.490 (m, SiCH2-CH2-CH2-Cl), 5.782-6.201 (m, (CH2=CH)3-Si-).
2.7.1.2. Synthesis of 3-iodopropyltrivinylsilane
A flame dried, 500ml round bottom flask equipped with a stir bar, condenser and
purged

with

nitrogen

was

charged

with

15.0

g

(83.0

mmol)

of

3-

chloropropyltrivinylsilane. Sodium iodide 24.88 g (166.0 mmol) was added to a 250 mL
round bottom flask and dissolved in 160 mL of acetone. The sodium iodide solution was
then syringed into the 500 mL flask and heated at 56 °C for 24 hours. The acetone was
then removed under vacuum and the product was dissolved in 250ml of DCM and
vacuum filtered to remove insoluble salt byproducts. The solvent was then removed by
rotary evaporation and the product was distilled at 100 °C at 0.8 torr. Yield (11.65 g)
1

HNMR (300 MHz, CDCl3, δ in ppm): 0.824 (m, Si-CH2-CH2-CH2-I), 1.871 (m, Si-CH2-

CH2-CH2-I), 3.165 (m, Si-CH2-CH2-CH2-I), 5.721-6.106 (m, (CH2=CH)3-Si-).
2.7.1.3. Synthesis of 3-hydroxypropyltrivinylsilane
Hexamethylphosphoramide (HMPA) (50 mL) was added to a 250 mL flame dried
round bottom flask equipped with a condenser, stir bar, and purge with nitrogen. Sodium
bicarbonate (3.40 g, 40.4 mmol) was added, followed by 11.0 g (40.4 mmol) of 3iodopropyltrivinylsilane. Water (6.54 mL, 363.0 mmol) was then added via syringe and
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stirred at 100 °C for 24 hours. 3-hydroxypropyltrivinylsilane was then extracted twice
with chloroform and distilled at 90 °C at 0.8 torr to receive pure product. Yield (8.95 g)
1

HNMR (300 MHz, CDCl3, δ in ppm): 0.713 (m, Si-CH2-CH2-CH2-OH), 1.616 (m, Si-

CH2-CH2-CH2-OH), 3.590 (m, Si-CH2-CH2-CH2-OH), 5.700-6.198 (m, (CH2=CH)3-Si-).
2.7.1.4. Anionic Ring Opening Polymerization of Ethylene Oxide using 3hydroxipropyltrivinylsilane
Ethylene oxide, 9.27 g (0.210 mmol), was distilled into 300 mL stainless steel
Parr Reactor cooled to -40 °C using an acetone dry ice bath, followed by 100 mL of
THF. In a separate 50 mL flame dried, round bottom flask with stir bar and under
nitrogen purge, 0.56 g (3.33 mmol) of 3-hydroxypropyltrivinylsilane was dissolved in 10
mL of THF. Via syringe, 3.31 mL of potassium naphthalenide solution (0.9 M) was
added and stirred until solution turned from a cloudy yellow to pink. The initiator
solution was then charged to the reactor via syringe, and followed by 50 mL of THF. The
reactor was brought to room temperature and held for 24 hours. Polymerization was
terminated with 1.32 mL of 2.5 M acetic acid solution in THF. The reactor was then
purged with nitrogen for 1hr. Solvent was removed by rotary evaporation, and dissolved
in 200 mL of chloroform. The solution was then washed with 150 mL of deionized water.
The organic layer was then concentrated down and precipitated using cold DEE and the
polymer was retrieved by filtration. The remaining polymer was dried in vacuum oven at
25°C (yield: 7.970 g). 1HNMR (300 MHz, CDCl3, δ in ppm): 0.73 (m, Si-CH2-CH2-CH2I), 1.63 (m, Si-CH2-CH2-CH2-I), 3.41 (m, Si-CH2-CH2-CH2-I), 5.71-6.19 (m,
(CH2=CH)3-Si-), 3.65 (m, (CH2-CH2-O)n).
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2.7.2. Results and Discussion
The polymer described in this section was synthesized to create a
heterobifunctional PEO that has multiple functional groups at one end that could be
modified with anchoring groups to increase the interaction with magnetic nanoparticles.54
To create the tri-functional PEO, an initiator was synthesized with three vinyl groups and
an alcohol that was utilized in creating the needed alkoxide to ring open ethylene oxide,
Figure 2.11.
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Figure 2.11. I) Synthesis of 3-chloropropyltrivinylsilane (CPTVS), II) 3iodopropyltrivinylsilane (IPTVS), III) 3-hydroxypropyltrivinylsilane (HPTVS)
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The first step in synthesizing the initiator involves the modification of 3chloropropyltrichlorosilane (CPTCS) with vinyl magnesium bromide via a Grignard
reaction, Figure 2.11 (I). Excess Grignard reagent was not used to limit the reaction with
the 3-chloropropyl end group and ensure the reaction was mainly with the silyl chlorides.
Using 1HNMR, the resonance peaks of the silyl vinyl groups appeared at 5.73 and 6.30
ppm (9H). These shifts for the silyl vinyl groups are found further downfield than
observed with the allyl-PEO-OH (Figure 2.6) due to the close proximity of the hydrogens
in the trivinyl groups that has caused desheilding of the protons to occur. The methylene
peaks of the 3-chloropropyl appeared at 3.49 (2H), 1.83 (2H), and 0.84 ppm (2H), shown
in Figure 2.12.
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Figure 2.12. 1HNMR spectrum of chloropropyltrivinylsilane
The second step taken was to synthesize 3-iodopropyltrivinylsilane (3-IPTVS),
which involved replacing the chloride with an iodide via an SN2 nucleophilic substitution,
Figure 2.11 (II). Chloride is a much stronger nucleophile than iodide, making iodine a
better leaving group. The substitution was confirmed by 1HNMR, Figure 2.13, by seeing
a small shift in the resonance of the methylene peaks adjacent to the iodine at 3.17 (2H).
The other methylene peaks were observed at 1.87 (2H) and 0.82 ppm (2H). The vinyl
silyl shifts were observed at 5.27 and 6.11 ppm (9H), indicating the vinyl groups are still
present following the reaction. There is a shift at 2.15 ppm due to some that was not
removed during purification.
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Figure 2.13. 1HNMR spectrum of iodopropyltrivinylsilane.
The final step, Figure 2.11 (III), in the synthesis of the trivinyl initiator involves
the transformation of the alkyl iodide to an alcohol via a SN2 reaction using a polar
aprotic solvent, HMPA. Conversion to alcohol was confirmed with 1HNMR by observing
a shift in the methylene peak from 3.17 ppm to 3.59 ppm. The chemical shifts were still
visible at 6.20 and 5.70 ppm and the proton ratios matched the predicted; 9:2:2:2, Figure
2.14. There was a singlet at 1.69 ppm due to water in the sample.
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Figure 2.14. 1HNMR spectrum of hydroxypropyltrivinylsilane.
Once the initiator was synthesized and characterized, it was used in the anionic
ring opening polymerization of ethylene oxide, shown in Figure 2.15. Using potassium
naphthalenide, the HPTVS was transformed into an alkoxide that will attack and open up
the ethylene oxide ring. The reaction was performed at room temperature at 40 psi for 24
hours. The pressure decreased about 10 psi, indicating most of the ethylene oxide had
been consumed in the reaction.
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Figure 2.15. Anionic ring opening polymerization of ethylene oxide using HPTVS
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OH

The resulting polymer was characterized by 1HNMR, Figure 2.16, showing
chemical shifts from the vinyl groups at 6.19 and 5.71 ppm. The methylene shift of PEO
was a 3.67 ppm and the methylene shifts close to the tri vinyl silyl group were at 3.41,
1.63, and 0.71 ppm. Number average molecular weight was calculated by comparing the
peak areas and was determined to be 6400 g mol-1. The number average molecular weight
determined from GPC was 6300 g mol-1 with a PDI of 2.1.
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Figure 2.16. 1HNMR of the anionic polymerization of ethylene oxide initiated by
HPTVS.
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2.8. ANIONIC RING OPENING POLYMERIZATION OF ETHYLENE OXIDE
USING 2-(TETRAHYDRO-2H-PYRAN-2-YLOXY)ETHANOL (THP) AS INITIATOR
2.8.1. Experimental
Ethylene oxide, 13.3 g (0.302 mmol), was distilled into 300 mL stainless steel
reactor cooled to -40℃ using an acetone dry ice bath, followed by 100 mL of THF. In a
separate 50 mL flame dried, round bottom flask with stir bar and under nitrogen purge,
0.64 mL (4.72 mmol) of 2-(tetrahydro-2H-pyran-2-yloxy)ethanol was dissolved in 10 mL
of THF. Via syringe, 4.75 mL of a potassium naphthalenide solution (0.9 M) was added
and stirred for 10 minutes. The initiator solution was then charged to the reactor via
syringe, and followed by 50 mL of THF. The reactor was brought to room temperature
and stirred for 72 hours. The polymerization was terminated with 1.90 mL of a 2.5 M
acetic acid solution in THF. The reactor was then purged with nitrogen for one hour to
remove any unreacted monomer. The solvent was then removed by rotary evaporation,
and the product was dissolved in 200 mL of chloroform. The polymer solution was then
washed with 150 mL of deionized water. The organic layer was then concentrated down
and precipitated using cold DEE and polymer was retrieved by filtration. The remaining
polymer was dried in vacuum oven at 25 °C (yield: 12.20 g). 1HNMR (300 MHz, CDCl3,
δ in ppm): THP: 1.475-1.812 (-CH-(CH2)3-CH2-), 3.852 (m, CH-(CH2)3-CH2-O-), 4.761
(t, -O-CH-O-). PEO: 3.630 (m, -(CH2-CH2-O)n-).
2.7.2. Results and Discussion
When synthesizing heterobifunctional polymers, protecting groups are necessary
to ensure only one end is functionalized without disturbing the other. Tetrahydropyranol
(THP) is a common hydroxyl-protecting group that is stable under non acidic
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conditions.127 It can be easily cleaved by using an acid to produce a hydroxyl terminus
that can be modified further.119 2-(tetrahydro-2H-pyran-2-yloxy)ethanol was used as an
anionic initiator to grow ethylene oxide, Figure 2.17. The reaction was performed at room
temperature at 40 psi for 72 hours. The reaction was terminated after the pressure
decreased about 10 psi, indicating all of the ethylene oxide has been used.
O

1.
O
O
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O

2.

O

O
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Figure 2.17. Anionic ring opening polymerization of ethylene oxide using 2
The polymer end group functionality and molecular weight was determined by
1

HNMR, Figure 2.18. The signals for the hydrogen in the THP protective group were

observed at 4.76 (1H), 3.85 (2H) and 1.81-1.48 ppm (6H). The characteristic methylene
peak of PEO was found at 3.63 ppm (328H). The number average molecular weight was
calculated by comparing the ratio of the integration of the signals of the THP to the
methylene signals of PEO; 2500 g mol-1. The GPC result, calculated from a series of PEO
standards, was determined to be 2150 g mol-1.
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Figure 2.18. 1HNMR spectrum of anionic ring opening polymerization of ethylene oxide
using 2-(tetrahydro-2H-pyran-2-yloxy)ethanoxide
2.9. ANIONIC RING OPENING POLYMERIZATION OF ETHYLENE OXIDE
USING POTASSIUM BIS(TRIMETHYLSILYL) AMIDE AS INITIATOR
2.9.1. Experimental
Ethylene oxide, 9.03 g (0.205 mol), was distilled into 300 mL stainless steel Parr
Reactor cooled to -40℃ using an acetone dry ice bath, followed by 100 mL of THF. At
-35 °C, 1.80 mL (8.26 mmol) of potassium bis(trimethylsilyl)amide solution was charge
to the reactor followed by 10 mL of THF. The reactor was brought to room temperature
and reacted for 36 hours. The reactor was then purged with nitrogen for 1 hour. Solvent
was removed by rotary evaporation, and the polymer was dissolved in 200 mL of
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0

chloroform. The solution was then filtered and the filtrate was then concentrated down
and precipitated using cold DEE and polymer was retrieved by filtration. The remaining
polymer was dried in vacuum oven at 25 °C (yield: 7.74 g). Removal of the trimethylsilyl
groups was accomplished by dissolving the polymer in methanol and then slowly adding
20 drops of 1N HCl and stirred for 24 hours at room temperature. The polymer was
precipitated with DEE and polymer was collected by filtration and dried in a vacuum
oven at 25 °C. 1HNMR (300 MHz, CDCl3, δ in ppm): 2.81 (t, NH2-CH2-), 2.754 (s, NH2CH2-), 3.635 (m, -(CH2-CH2-O)n.
2.9.2. Results and Discussion
Potassium bis(trimethylsilyl)amide is a commercially available compound that
can be used as an initiator to polymerize ethylene oxide with a primary amine on one end
and a hydroxyl group on the other after acid treatment, Figure 2.19.128 The
polymerization was done at room temperature for 36 hours at 40 psi and was terminated
when the pressure in the reaction vessel dropped 7 psi. After purification via precipitation,
the collected polymer was characterized with 1HNMR and GPC to confirm end groups
and determine molecular weight.
CH3

H 3C
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Si
H 3C
H 3C
H 3C

N
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CH3

Figure 2.19. Anionic ring opening polymerizaion of ethylene oxide using potassium
bis(trimethylsilyl)amide.
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Figure 2.20 shows the broad primary amine signal and the adjacent methylene
triplet signal overlap at 2.81 and 2.75 ppm respectively. The methylene signal was
observed at 3.64, confirming polyethylene oxide was formed. The molecular weight was
determined to be 4978 g mol-1 by comparing the ratio of the signal areas from the primary
amine end group and the methylene shifts of PEO. Using polystyrene standards, GPC

B
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H 2N

C

OH
O

n

0.7
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1.0
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was used to determine the molecular weight to be 19776 g mol-1 with a PDI of 4.724.
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Figure 2.20. HNMR spectrum of the anionic ring opening polymerization of ethylene
oxide using potassium bis(trimethylsilyl)amide as an initiator.
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2.10. CREATING HETEROBIFUNCTIONALITY THROUGH END GROUP
MODIFICATION
This section describes multiple methods used to create a desired functionality
through the modification of an alcohol terminus. These synthetic techniques will prove
useful in creating a variety of heterobifunctional polymers for almost any application.
2.10.1 Modification of an alcohol terminus to a carboxylic acid
2.10.1.1. Experimental
THP-PEO-OH used in this modification was synthesized as described in section
2.7. THP-PEO-OH (2 g, 0.627 mmol), succinic anhydride (0.105 g, 1.05 mmol), and
DMAP (0.009g, 0.07 mmol) was added to a flame dried 50 mL flask equipped with a stir
bar and dissolved in 20 mL of anhydrous THF. The flask was capped and purged with
nitrogen. The reaction was done at room temperature for 12 hours and then precipitated
with cold DEE. The collected polymer was then dissolved in chloroform and precipitated
again with cold DEE, this precipitation was repeated, and the polymer collected was
dried in a vacuum with no heat. (Yield 1.89 g) 1HNMR (300 MHz, CDCl3, δ in ppm):
2.72 (m,-OOC-CH2-CH2-COOH), 3.61 (m, -(CH2-CH2-O)n., and 3.87, m( -CH2-CH2-OCOO-).
2.10.1.1. Results/Discussion
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Figure 2.21. End group modification of THP-PEO-OH with carboxylic acid using
succinic anhydride.
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The esterification of the alcohol terminus with succinic anhydride, shown in
Figure 2.21, is a common reaction that can be a very useful intermediate for synthesizing
different heterobifunctional polymers129 as well as react with certain proteins.120 The end
group functionalization was confirmed by 1HNMR, showing characteristic shift at 3.61
ppm (2H) indicating ester linkage of the PEO to the succinic anhydride. The shift of the
hydrogen of the two methylene groups located between the carbonyl groups of the
succinic anhydride were found at 3.87 ppm (4H).
2.10.2. Modification of Alcohol Terminus with NitroDOPA
2.10.2.1. Experimental
The polymer used in this section was modified with a carboxylic acid using the
method described in section 2.9.3. PEO-COOH (1.8g , 0.5 5mmol) was added to a flame
dried flask equipped with a stir bar, along with NHS (0.063 g, 0.55 mmol) and DCC
(0.141 g, 0.684 mmol) and dissolved in anhydrous THF. The flask was sealed and was
reacted for 8 hours at room temperature under a nitrogen head.
The reaction was then vacuum filtered to remove any insoluble N,N’dicyclohexylurea and then precipitated with cold DEE and the white precipitant was
collected. The white precipitant was then dissolved in chloroform and precipitated with
cold DEE two more times. The white precipitate was collected and dried under vacuum.
(Yield 1.55 g) 1HNMR (300 MHz, CDCl3, δ in ppm): 2.804 (m,-OOC-CH2-CH2-COO-),
2.690 (s,-CH2-CH2- of NHS), 3.631 (m, -(CH2-CH2-O)n).
NitroDOPA, a catechol amine, is a desirable end group for many polymers
because of its strong binding affinity to metal oxides.130. The PEO was now equipped
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with an end group that would easily react with amines, Figure 2.22. This was taken
advantage of by reacting it with the amine of nitroDOPA, shown in Figure 2.23. The
resulting polymer was then precipitated with cold DEE to remove the byproduct of NHS.
The precipitate was then dissolved in chloroform and vacuum filtered to remove any
unreacted nitroDOPA. The filtrate was then precipitated with cold DEE and the resulting
polymer was collected and stored in chloroform. 1HNMR (300 MHz, CDCl3), δ (ppm):
3.64 (m, CH2-CH2-O), NitroDOPA: 6.12 and 6.90 (s, CH in ring).
2.10.2.2. Results and Discussion
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Figure 2.22. End group modification of THP-PEO-COOH with NHS intermediate.
NHS is commonly used as an intermediate to react with primary amines.120,131 It is
also a popular synthetic technique used in linking bioconjugates to polymers.132-134 A
PEO previously modified with a carboxylic acid was activated with NHS in preparation
to react with the amine of nitroDOPA, Figure 2.22. The reaction was performed in
anhydrous THF for 12 hours with DCC. Precipitation of insoluble N,N’dicyclohexylurea
indicated the reaction took place and it was removed by filtration. 1HNMR was used to
confirm NHS-ester linkage. The methylene shift of the NHS end group was indicated by
a singlet at 2.69 ppm (4H).
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Figure 2.23. End group modification of THP-PEO-NHS with nitroDOPA.
Once the PEO-NHS intermediate (0.2 g, 0.059 mmol) was synthesized and
characterized, it was then reacted with nitroDOPA (0.017 g, 0.071 mmol), a catechol
amine, in anhydrous DMF for 12 hours, Figure 2.23. The reaction was purified by
precipitation with DEE. It was then dissolved in chloroform and the filtered to remove
any unreacted nitroDOPA that is insoluble. The modification was confirmed by 1HNMR
with the appearance of shifts at 6.05 and 6.90 ppm, which are the proton resonance of the
benzene ring of the nitroDOPA.
2.10.3. Modification of the Alcohol Terminus to an Alkyne
2.10.3.1 Experimental
A THP-PEO-OH, synthesized as describe in section 2.7, was used and was
modified with an alkyne, shown in Figure 2.24, using the following procedure. THPPEO-OH (1.5 g, 0.35 mmol) and sodium hydride (0.03 g, 1.3 mmol) were charged to a
flame dried round bottom flask equipped with a stir bar and dissolved in 40 mL of THF.
The reaction was brought to 0 °C using a salt ice bath and 120 µL of propargyl bromide
solution (1.4 mmol) was slowly added over 30 minutes at 0 °C. Once all the propargyl
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bromide was added, the reaction was stirred for another 30 minutes at 0 °C and then
removed from ice bath to warm to room temperature and react for 24 hours. The resulting
polymer was precipitated with cold DEE three times and solid was collected and dried
under vacuum. The polymer was then dissolved in 20 mL of methanol and 20 drops of
one molar HCl solution was slowly added. The reaction was stirred for 24 hours at room
temperature to remove the protecting group. The polymer was the precipitated with cold
DEE. The collected polymer was then dissolved in chloroform and precipitated again
with cold DEE. The resulting solid was collected and dried under vacuum. Yield: 0.91 g.
1

HNMR (300 MHz, CDCl3, δ in ppm): 2.43 (m, CH≡C-CH2-), 4.19 (m, CH≡C-CH2-),

3.65 (m, -(CH2-CH2-O)n).
2.10.3.2. Results and Discussion
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Figure 2.24. End group modification of THP-PEO-OH with probargyl bromide to give
alkyne functionality.
Modification of a hydroxyl-terminated PEO with an alkyne group was completed
using a substitution reaction with propargyl bromide, shown in Figure 2.22. The
functionalization of PEO with an alkyne will allow for further derivation with azidefunctionalized molecules via a 1,3 dipolar cycloaddition between the two functionalities
to form a triazole linkage, which is a reaction that is synonymous with “click chemistry.”
119,135

The reaction took place under room temperature conditions in anhydrous THF for

24 hours. Sodium hydride was used to catalyze the SN2 reaction, producing an ether
linkage connecting the propargyl group to the hydroxyl group of the PEO. 1HNMR
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confirmed the modification with an alkyne. The chemical shifts for the single proton of
the on the alkyne was observed at 2.43 ppm (1H) and the methylene peak two carbons
over showed proton resonance at 4.19 ppm (2H).
2.10.4. Modification of the Alcohol Terminus to a Methacrylate
2.10.4.1. Experimental
A (TMS)2-N-PEO-OH, was synthesized as describe in section 2.8 was used and
was modified with an alkyne using the following procedure. (TMS)2-N-PEO-OH (1.0 g,
0.2 mmol) and sodium hydride (0.03 g, 0.8 mmol) were charged to a flame dried round
bottom flask equipped with a stir bar and dissolved in 40 mL of THF. The reaction was
brought to 0 °C using a salt ice bath and 80 µL of methacryloyl chloride solution (0.8
mmol) was slowly added over 30 minutes at 0 °C. Once all the methacryloyl chloride was
added, the reaction was stirred for another 30 minutes at 0 °C and then removed from ice
bath to warm to room temperature and react for 24 hours. The polymer was then
dissolved in 20 mL of methanol and 20 drops of 1M HCl solution was slowly added. The
reaction was stirred for 24 hours at room temperature to remove the TMS protecting
groups. The polymer was the precipitated with cold DEE. The collected polymer was
then dissolved in chloroform and precipitated again with cold DEE. The resulting solid
was collected and dried under vacuum. Yield: 0.711 g. 1HNMR (300 MHz, CDCl3, δ in
ppm): 6.13 and 5.57(t, CH2=C(CH3)-CH2-), 4.19 (t, -C(=O)-O-CH2-), 3.64 (m, -(CH2CH2-O)n), 1.95(s, CH2=C(CH3)-CH2-).
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2.10.4.2. Results and Discussion
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Figure 2.25. End group modification of PEO-OH with methacrylol chloride.
Hydroxyl terminated PEO was modified with methacrylol chloride using a SN2
reaction, catalyzed with NaH. The polymer was characterized with 1HNMR and
modification was easily confirmed by the appearance of shifts at 6.13 and 5.57 ppm(2H)
for the hydrogen of the terminal vinyl group. The methyl group on the methacrylate end
group appeared at 1.95 ppm and the methylene hydrogens of the ethylene oxide repeat
unit with a multiplet at 3.64 ppm. PEO with a methacrylate end group can be very useful
in creating star graft copolymers,136 drug modification using thiol-ene chemistry,103 and
crosslinking of magnetic nanoparticles to increase magnetic response.137
2.11. CONCLUSION
Polyethylene oxide is very versatile polymer that can be used in a variety of
applications. Developing skills of polymer synthesis and endgroup modification will
allow for an arsenal of heterobifunctional polyethers that can be used for surface coatings
that will provide functionality. These synthetic techniques are not limited to PEO oxide;
they are well-studied techniques that can be applied to other polymer systems. The
polymers described in this chapter were synthesized and modified with relative ease and
the techniques were used in later chapters to synthesize specialized polymers that will be

57

used to modify magnetic nanoparticles for biomedical applications, described in later
chapters.
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CHAPTER 3. SYNTHESIS AND CHARACTERIZATION OF
HETEROBIFUNCTIONAL POLY(ETHYLENE OXIDE) PLATFORM FOR
BIOMEDICAL MAGNETIC NANOPARTICLES
3.1. ABSTRACT
Contemporary magnetic nanoparticle composites are individually designed for a
specific application: magnetic hyperthermia, cell separation, and MRI contrasts agents.
The work that is described here involves the synthesis of a single magnetic nanoparticle
composite with a surface that can be customized for any application. The discussion of
the syntheses and characterization of a heterobifunctional polyethylene oxide (PEO)
using nitroDOPA as a robust anchoring group on one end and an alkyne as the reactive
surface for additional application specific modification. The potential for these scaffolds
allows them to be utilized in a variety of research fields because of the efficiency and
ease of modification that is inherit in the Huisgen 1,3-dipolar cycloaddition between an
azide and alkyne, commonly known as “click chemistry.” Synthesis of this specialized
polymer-particle complex exhibited biological stability and modifiable surface by
attaching a fluorescent dye using “click chemistry.”
3.2. INTRODUCTION
Magnetic nanoparticles are ideal materials for bioimaging,138 therapy and
delivery.139 These blossoming technologies are not possible without designing and
synthesizing specialized materials to stabilize the magnetic nanoparticles in biological
environments. For the stabilizing layer, the material must be biologically inert and have
sufficient steric hindrance to provide a long circulation time in the body.140 To increase
efficiency of materials used in biological imaging, therapy and delivery, the surface must
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be enhanced with biological targeting and labeling molecules to both increase the
concentration of the particles in the desired location of the body and to monitor the
particles’ fate.141
When designing polymer-particle systems for biomedical applications, it is very
important to have a robust anchor to ensure particle stability in protein rich environments.
Some traditional anchor groups studied for iron oxide nanoparticles are carboxylic
acids,54 alcohols,55 amines,56 silanes,142 ammonium,143 and phosphates.58 Another
molecule being heavily researched as a robust anchor for iron oxide nanoparticles are
catechols, which were inspired from a protein adhesive featured in mussels.144 Catecholderived ligands have been found to displace other binding groups on the surface of iron
oxide145 as well as create stable particles in physiological conditions.66,146 The catechol
groups used for anchoring to iron oxide are generally found in dopamine-derived
molecules that can be attached to polymers through the terminal amine using a common
crosslinking chemistry that utilizes N-hydroxysuccinimide (NHS) esters to activate
carboxylic acid for reactions with amines.131
In this chapter, a heterobifunctional polyethylene oxide (PEO) ligand was
synthesized for the stabilization and functionalization of magnetic nanoparticles.
Utilizing ordinary chemistry, a synthetic route was developed that produces a
heterobifunctional PEO ligand with a robust anchoring group and a reactive surface. PEO
is ideal for theranostic systems, term used to describe particles that can be used for both
therapeutic and diagnostic applications, not only because of how inert the backbone is to
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protein absorption,147 but this relatively unreactive polymer chain allows for modification
of the end groups with relative ease.114
3.3. EXPERIMENTAL
3.3.1. Synthesis of nitroDOPA
In a 50 mL round bottom flask, equipped with a stir bar, 30 mL of DI water was
cooled in a brine salt bath to 0 ºC before adding sodium nitrite (1.52 g, 17.88 mmol) and
L-3,4-dihydroxyphenylalanine (L-DOPA) was added (1.97 g, 9.99 mmol) and allowed to
cooled. While stirring, 0.92 mL (90.23 mmol) of sulfuric acid was added dropwise to
form an orange precipitate. Once all of the acid was added, the solution was stirred
overnight. The product was collected by vacuum filtration, washed with methanol, and
dried in a vacuum oven (30% yield).
1

HNMR (300 MHz, DMSO-D6), δ (ppm): 7.46 and 6.84 ppm (s, CH, ring,

nitroDOPA), 3.54-3.49 ppm (t, J=15, -CH2-CH-N-), 3.31-2.98 ppm (m, -CH2-CH-N-),
13

CNMR (300 MHz, DMSO-D6) δ (ppm): 170.7, 153.4, 145.2, 139.2, 126.9, 119.9, 112.6,

54.8, 40.0, 35.4.
3.3.2. Synthesis of THP-PEO-OH
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Figure 3.1. Anionic ring opening polymerization of ethylene oxide using THP initiator.
EO (13.3g, 0.30 mol) was distilled into 300 mL stainless steel reactor cooled to 40 °C using an acetone dry ice bath, followed by 100 mL of THF. In a separate 50 mL
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flame dried, round bottom flask with stir bar and under nitrogen purge, dissolved 2(tetrahydro-2H-pyran-2-yloxy)ethanol (0.65 mL, 4.72 mmol) in 10 mL of THF. Via
syringe, 4.75 mL of potassium naphthalenide (0.9 M) was added and stirred for 10
minutes. The initiator solution was then charged to the reactor via syringe, and followed
by 50ml of THF. The reactor was brought to room temperature and held for 72 hours.
Polymerization was terminated with 1.90 mL of 2.5 M acetic acid solution in THF. The
reactor was then purged with nitrogen for 1hr. Solvent was removed by rotary
evaporation, and then dissolved in 200 mL of chloroform. The solution was then washed
with 150 mL of deionized water. The organic layer was then concentrated down and
precipitated using cold DEE and polymer was retrieved by filtration. The remaining
polymer was dried in vacuum oven at 25 °C and characterized by 1HNMR. Molecular
weight was calculated by comparing the ratio of the area of THP to the polyethylene
backbone and was found to have a molecular weight of 6300 g mol-1.
1

HNMR (300 MHz, CDCl3), δ (ppm): THP: 1.47-1.88 (m, CH-(CH2)3-CH2), 3.87

(m, CH-(CH2)3-CH2-O), 4.61 (t, J=6.9, O-CH-O). PEO: 3.64 (m, CH2-CH2-O).
3.3.3. Synthesis of THP-PEO-Alkyne
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Figure 3.2. End group modifcation of THP-PEO-OH with propargyl bromide.
A 100ml round bottom flask was equipped with a stir bar and flame dried. The
flask was then charged with THP-PEO-OH (2.0g, 0.33 mmol) and sodium hydride (0.024
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g, 1.0 mmol) and finally sealed and purged with nitrogen. THF (20 mL) was then added
via syringe to dissolve reactants and was brought to 0 °C using a NaCl ice bath for 30
minutes. Propargyl bromide (0.09 mL, 1.0 mmol) was added slowly via syringe over 30
minutes, followed by 30 minutes of stirring at 0 °C. The reaction was removed from ice
bath and warmed to room temperature and stirred for 24 hours. The final solution was
filtered via vacuum filtration and subsequently precipitated twice with DEE. The final
product was dried in vacuum overnight.
1

HNMR (300 MHz, CDCl3), δ (ppm): 1.47-1.88 (m, CH-(CH2)3-CH2), 4.63-4.61

(t, O-CH-O), 3.64 (m, CH2-CH2-O), 2.43-2.44 (t, -O-CH2-C≡CH), 4.198-4.190 (d, -OCH2-C≡CH)
3.3.4. Deprotection of THP-PEO-Alkyne
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Figure 3.3. Cleavage of tetrahydropyranol to yield alkyne-PEO-OH
THP-PEO-alkyne (0.8 g, 0.17 mmol) was dissolved in 10 mL of methanol. Three
drops of 1 M HCl solution were added and the solution and stirred for 4 hours. The
product was recovered by crashing into DEE, and solid was collected using vacuum
filtration. The product was characterized by 1HNMR.
1

HNMR (300 MHz, CDCl3), δ (ppm): 3.64 (m, CH2-CH2-O), 2.42-2.44 (t, -O-

CH2-C≡CH), 4.187-4.195 (d, -O-CH2-C≡CH)
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3.3.5. Synthesis of Alkyne-PEO-COOH
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Figure 3.4. Modification of alcohol terminus with carboxylic acid using succinic
anhydride.
A round bottom flask equipped with a stir bar was flame dried and charged with
alkyne-PEO-OH (0.8 g, 0.17 mmol) and placed in a vacuum oven for 30 minutes at 80 °C.
SA (0.03 g, 0.27 mmol) and DMAP (0.002 g, 0.02 mmol) were added to round bottom
flask and then it was purged with nitrogen. Finally, anhydrous THF (20 mL) was then
added to the flask via syringe and stirred for 8 hours. The reaction was then precipitated
with cold DEE. The precipitant was collected and dissolved in 5 mL of DCM and
precipitated again with cold DEE (2X). The final precipitant was collected and dried in a
vacuum oven overnight. The polymer was characterized using 1HNMR.
1

HNMR (300 MHz, CDCl3), δ (ppm): 3.64 (m, CH2-CH2-O), 2.58 (m,-CH2-CH2-

C(O)-O-), 2.42-2.44 (t,-O-CH2-C≡CH), 4.187-4.195 (d, -O-CH2-C≡CH)
3.3.6. Synthesis of Alkyne-PEO-NHS
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Figure 3.5. PEO-alkyne modified with NHS intermediate
In a flame dried, 25 mL round bottom flask with a stir bar, alkyne-PEO-COOH
(0.73 g, 0.15 mmol), NHS (0.02 g, 0.18 mmol), and DCC (0.04 g, 0.18 mmol) were
added, capped and purged with nitrogen. THF (20 mL) was added via syringe and was
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reacted for 4 hours at room temperature. The solution was then vacuum filtered to
remove any dicyclohexylurea that precipitated during the reaction. Using rotary
evaporation, the THF was removed from the filtrate and the product was dissolved in 5
mL of DCM and precipitated with DEE (2x). The precipitate was collected and dried in a
vacuum oven (83% yield). The product was characterized by 1HNMR.
1

HNMR (300 MHz, CDCl3), δ (ppm): 3.64 (m, CH2-CH2-O), 4.22 (m, -CH2-O-

C(O)-), 2.72 (m,-CH2-CH2-C(O)-O-), 2.42-2.44 (t, -O-CH2-C≡CH), 4.19-4.20 (d, -OCH2-C≡CH), 2.80 (s,-C(O)-CH2-CH2-C(O)-).
3.3.7. Synthesis of Alkyne-PEO-NitroDOPA
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Figure 3.6. Modification of PEO with nitroDOPA
A flame dried, 50 mL Erlenmeyer flask equipped with a stir bar was charged with
alkyne-PEO-NHS (0.69 g, 0.14 mmol) and nitroDOPA (0.04 g, 0.17 mmol), capped, and
purged with nitrogen. Next, 10 mL of DMSO was added via syringe and stirred for 4
hours at room temperature. Finally, the resulting reaction was precipitated with DEE and
the product was dissolved in chloroform and filtered to remove any excess nitroDOPA.
The final polymer was precipitated with cold DEE, collected, and dried in vacuum oven
(87% yield). The final product was characterized using 1HNMR.
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1

HNMR (300 MHz, CDCl3), δ (ppm): 3.64 (m, CH2-CH2-O), 2.72 (m, -CH2-CH2-

C(O)-O-), 2.42 (s, -O-CH2-C≡CH), 4.20 (d, -O-CH2-C≡CH). NitroDOPA: 6.12 and 6.70
(s, CH in ring).
3.3.8. Synthesis of magnetite nanoparticles
The 7.2 nm magnetic nanoparticles, synthesized using thermal decomposition of
iron(III) acetylacetonate (2 mmol), 1,2-hexadecanediol (10 mmol), oleylamine (4 mmol),
benzyl ether (20 mL), and 6 nm iron oxide seeds were added and stirred under a nitrogen
flow and brought to 200 °C for one hour to remove any moisture. Finally the reaction was
brought to reflux for 30 minutes under a nitrogen head. The particles were purified by
precipitation of ethanol and characterized using TEM and DLS.
3.3.9. Modification of magnetite nanoparticles
The magnetic nanoparticles were modified by first dissolving alkyne-PEOnitroDOPA (200 mg, 0.04 mmol) into 10ml of chloroform followed by the slow addition
of 1ml (2 mg of Fe3O4 mL-1) of magnetic nanoparticles, which were also dispersed in
chloroform, while sonicating over 30 minutes. The solution was allowed to stir overnight.
The particles were then purified by precipitation with hexane, centrifuged to separate
particles from solvent. They were then dispersed in ethanol and subsequently precipitated
using hexane and separated via centrifugation to collect particles. Finally, the particles
were dispersed in deionized water and dialyzed for 3 days.
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3.3.10. Functionalization of alkyne-PEO-nitroDOPA coated magnetic nanoparticles with
azido-functionalized dyes
Modification with azido-fluorescein dye
To 10ml of DI water, 0.2 mL of modified particles (0.7 mg of modified particles
mL-1) was added. The azido-fluorescein dye (0.003 mmol) was added to solution
followed by CuSO4 (0.013 mmol) and sodium ascorbate (0.003 mmol). The reaction was
then covered with foil and stirred at 32 °C for 24 hours. The particles were then removed
from heat and dialyzed for 2 days against DI water.
Modification with azido-fluorescein and carbazole dye
To 50ml of THF, 1ml of modified particles (4.11mg/mL) was added. Azidofluorescein (0.67mg, 0.001mmol) and azido-carbazole (0.21mg, 0.001mmol) was then
added to the solution. While stirring, 121 µL aqueous solution of CuSO4 (15mM) and
54µL aqueous of sodium ascorbate (11.1mM) was added to the solution and reacted for
24 hours at 32 °C. The particles were removed for heat and the THF was then removed
by rotary evaporation. The particles were then dispersed in 5ml of DI water and dialyzed
for 3 days against DI water.
3.4. RESULTS AND DISCUSSION
The synthetic design begins with the anionic ring opening polymerization of
ethylene oxide using 2-(tetrahydro-2H-pyran-2-yloxy)ethanol (THP) as the alkoxide
initiator (Figure 3.1), based on previous work by Hiki et al.119 This synthetic approach is
ideal for creating narrow molecular weights and is more efficient than partial derivation
of diols.114 Beginning with one protected end group allows for precise and efficient
modification for desired heterobifunctionality. With one of the end groups protected, the
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free alcohol was modified with propargyl bromide via a substitution reaction to produce
the alkyne functionality needed (Figure 3.2). After cleaving the tetrahydropyranol
protecting group with an acid (Figure 3.3), the other alcohol was free to be modified.
Through a series of reactions, which included modification with succinic anhydride (SA)
(Figure 3.4) and the N-hydroxysuccinimide (NHS) (Figure 3.5), the polymer was primed
to be modified through the amine of nitroDOPA (Figure 3.6).
NitroDOPA was synthesized using a procedure by Yang et al148 and used as our
anchoring system based on a study by Amsted et al that compared the stability of a
variety of catechol complexes in which they found nitroDOPA having one of the higher
binding affinities.62 Using 13CNMR (Figure 3.7) and FT-IR (Figure 3.8), nitration of the
DOPA was confirmed by the symmetric and asymmetric stretching peaks at 1330 and
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Figure 3.7. 13CNMR spectra of nitroDOPA in D2O
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Figure 3.8. Interferogram of DOPA (top) and nitroDOPA (bottom). Symmetric and
asymmetric stretching peaks at 1330 and 1532 cm-1 confirm nitration.
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Figure 3.9. TEM micrograph of iron oxide nanoparticles synthesized via thermal
decomposition with a mean size of 7.2nm ± 0.9.
Monodispersed iron oxide nanoparticles in hexane were synthesized using a
method from Sun et al.149 The particles core size was found to be 7.2 nm ± 0.9 nm in
diameter by TEM (Figure 3.9) and the hydrodynamic diameter was found to be 29.2 ±
17.1 nm (Table 3.1). The particles were then modified via ligand exchange using PEO
modified with nitroDOPA. Sonication and stirring overnight aided in the replacement of
the oleylamine, a hydrophobic ligand, with the polymer ligand in chloroform. The
particles were then precipitated with an anti-solvent and finally dispersed into DI water.
PEO with a molecular weight of 6000 g mol-1 was used to modify the particles because it
provides sufficient steric hindrance to avoid agglomeration due to the magnetic nature of
the particles. Because the human circulatory system is sensitive to objects with a size
greater than 200 nm, the brush sized used will provide a small enough platform for
modification with large functional moieties to stay below the size range that can be
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filtered out. The particles dispersed in DI water was a great indicator that the particles
were successfully modified with PEO (Figure 3.10), and TEM micrograph (Figure 3.10)
shows a halo from the less dense polymer around the dense magnetic nanoparticles. If
the polymer chains were fully extended, the chain length is about 34 nm, giving a total
polymer-particle diameter of 61 nm. When analyzing the dry diameter of 10 particles, the
average diameter measured was 42 nm, which is within the size range expected for the
molecular weight used to modify the 7.2 nm magnetic nanoparticles.

Figure 3.10. Schematic of a magnetic nanoparticle modified with alkyne-PEOnitroDOPA (left) and TEM micrograph of particles after modified with alkynePEO-nitroDOPA (right).
When creating nanoparticles for biological applications, analyzing the particleenvironment interaction is important.57,131 Characterizing these particles in ionic and
protein rich solutions is a great technique for simulating stability in biological
environments. Using dynamic light scattering (DLS), modification of the aforementioned
7.2 nm oleylamine coated nanoparticles with the water soluble PEO was confirmed. The
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final hydrodynamic diameter was an average of 77 nm in water, as shown in Table 3.1.
For drug delivery systems, this size will be able to circulate within the body without
getting filtered out by the reticulo-endothelial system (RES).150 The particles were further
characterized with thermogravometric analysis (TGA) (Figure 3.11) to find the surface
loading of polymer on the surface of the particle. There was about a 95% weight loss of
polymer, which comes out to be about 11 chains per nm2, suggesting some free polymer
still associated with the particles after 3 days of dialysis. Initially, it was presumed that
some oleic acid, used to suspend the particles before they were modified with polymer,
might have been trapped on the surface during modification. TGA analysis of the
particles before they were modified with polymer showed an 87% weight loss from 179233 °C due to the oleic acid. This feature is not observed in the TGA of the modified
particles, Figure 3.11. So, the high loading of polymer on the surface could be due to
crosslinking between the nitroDOPA endgroups that can create a large macromolecule
that was not removed with the molecular weight cutoff used for dialysis.
Table 3.1. DLS of magnetic nanoparticles before and after modification.
Z-Avg (d.nm)

PDI

I (%, d.nm)

V (%, d.nm)

N (%, d.nm)

OA Coated

29.24

0.295

35.42±17.14

20.06±8.93

14.57±4.51

PEO-Coated

77.31

0.138

89.49±31.65

66.83±25.72

51.52±14.73
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Figure 3.11. Thermograph of particles modified with alkyne-PEO-nitroDOPA
Although the particles are stable in water, this is irrelevant in the complex
environment of the human body. Materials used in biological applications can be limited
in their effectiveness due to absorption plasma proteins that can inhibit the circulation
time in the body.151 Proteins can attach to the particles and provoke agglomeration
rendering the particles useless. To observe how this particles system will behave in a
simulated biological environment, phosphate buffer saline (PBS), fetal bovine serum
(FBS), and bovine serum albumin (BSA) were added, 10% by volume (0.1 mL), to a
dilute solution of the particles (0.9 mL, 0.1 mg of modified particles mL-1), to see how
the hydrodynamic diameter was affected, thus indicating the colloidal stability in the
respected media.152 As seen in Figure 3.12, there was no significant change in
hydrodynamic diameter observed when the particles were put in ionic and protein rich
environments.
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Figure 3.12. (Left) Hydrodynamic diameter by intensity of magnetic nanoparticles before
and after modification with alkyne-PEO-nitroDOPA; size data chart available
(Right) Hydrodynamic diameter by intensity of the particles titrated with PBS,
FBS, and BSA.
Now that this polymer-particle complex has been successfully synthesized and
characterized in simulated biological environments, the functional surface can be
modified for biomedical targeting and imaging applications. Fluorescein-azide, Figure
3.13 (B), was then “clicked” in using a Huisgen 1,3-dipolar cycloaddition between the
alkyne of the particle surface and the azide of the fluorescent dye molecule, using copper
(II) sulfate and sodium ascorbate to drive the reaction.153 These particles were dialyzed
for 3 days in the absence of light to ensure removal of excess dye, catalyst and
byproducts. The photoluminescence spectrum (Figure 3.14) shows a maximum emission
at 517 nm for the particles modified with fluorescein and no visible emission for the
particles before modification.
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Figure 3.13. Schematic of azide modified dyes used to modify magnetic nanoparticles
using “click chemistry.” A) carbazole modified with an azide and B) fluorescein
modified with an azide.

Figure 3.14. Image on the left shows a photoluminescence spectrum of particles before
and after functionalization with fluorescein. Image on the right represents the
final construction of magnetic nanoparticle with functional surface modified
with a fluorophore.
To demonstrate the versatility of the alkyne surface, the particles were then
modified with equimolar amounts of carbazole and fluorescein dye, Figure 3.13 (A) and
(B) respectively. These two dyes were chosen because their emissions are at different
wavelengths, carbazole at 350 and 366 nm154 and fluorescein at 515 nm.155 After the
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particles were modified, dialysis against water was done for 3 days to ensure excess dye
and catalyst was sufficiently removed. Photoluminescence was then used to conform the
modification of the particles by first exciting at 290 nm to yield a broad emission peaks at
348 and 363 nm, Figure 3.15 (A). The same sample was then excited at 400 nm and an
emission was observed at 417 nm, Figure 3.15 (B).

Figure 3.15. Photoluminescence of mono-anchored nanoparticles after modification with
A) carbazole dye (348 and 363 nm) and B) fluorescein dye (417 nm).
3.5. CONCLUSIONS
The design and synthesis of this specialty heterobifunctional PEO provides a great
platform for biomedical magnetic nanoparticle research. This uncomplicated synthesis of
such a specialized material lends itself to the production of biologically stable
nanoparticles with an alkyne surface that provides a customizable scaffold for a variety of
biomedical applications.
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Synthesis of a unique heterobifunctional PEO was accomplished by ring opening
polymerization of EO using a protected initiator and sub-sequential end group
modifications with relative ease. This polymer is equipped with robust anchoring to
magnetite via a catechol, biological stability via PEO, and a functional surface via an
alkyne. Confirmed by DLS, the once water-insoluble magnetite nanoparticles, were
stabilized in water. These functionalized particles are now capable of carrying a variety
targeting and imaging agents, through “click chemistry,” which is represented in the
drawing in Figure 1.4. The accessibility of the surface functionality was demonstrated by
adding an azido-functionalized fluorescein that was detected using photoluminescence, at
a wavelength of 517 nm. The ability to add multiple functional moieties of the surface
was also displayed using two different dyes (carbazole and fluorescene) that emit at
different wavelengths that could easily be characterized by photoluminescence. The
development of this polymer-particle complex allows for a biologically stable platform to
easily and efficiently build biomedical devices for use in any theranostic application.
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CHAPTER 4. SYNTHESIS AND CHARACTERIZATION OF MULTI-ANCHORED
HETEROBIFUNCTIONAL POLY(ETHYLENE OXIDE) FOR ENHANCED
STABILITY AND FUNCTIONALITY OF MAGNETIC NANOPARTICLES
4.1. ABSTRACT
The research and development of surface coatings for magnetic nanoparticles is
important for improving colloid stability of these particles in biological conditions. For
efficient delivery of the magnetic nanoparticles, they must remain stable for long enough
in the harsh environment of the body to get sufficient concentration to the infected area.
Improved stability can be accomplished by increasing the number of interactions between
the surface coating and the magnetic nanoparticles to decrease the interactions of proteins
that can interfere with colloidal stability. This chapter discusses the synthesis of a
heterobifunctional polyethylene oxide (PEO), with an amine on one end and an alkyne on
the other, which is chemically attached to polyacrylic acid (PAA) and subsequently
modified with nitroDOPA to provide multiple anchoring groups per PEO chain.
Improved stability was not only observed, by comparing it to a mono-anchored PEO in
extreme ionic and protein rich environments, but there is an alkyne surface on the particle
that can be modified, in water, with azide-functionalized moieties using “click chemistry.”
4.2. INTRODUCTION
Functional magnetic nanoparticles have become an important research focus for
use in biomedical applications. These applications include magnetic hyperthermia,2,156
magnetic resonance imaging,20,21 and cell separation.22,23 The small size and manipulation
of magnetic properties of these materials also have potential for non-invasive diagnostics
and treatments to improve quality of life for patients.
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There are a variety of ways to create functional magnetic nanoparticles, but the
fundamental designs of these materials stay the same. Generally, in each individual
nanoparticle, the core material is magnetic and is coated with a water-soluble material
that is either physically or chemically adsorbed on to the surface. The core can be made
up of an assortment of magnetic materials, including iron platinum, cobalt oxide, and iron
oxides.139 Because these materials are synthesized using thermal decomposition methods,
they have hydrophobic ligands that are only dispersible in organic solvents. They must be
modified with hydrophilic materials for biomedical applications. There are a variety of
hydrophilic surface designs that have been researched to create magnetic nanoparticles
suspended in water, including dextran, pluoronics, and polyethylene oxide (PEO).139
Magnetic nanoparticles for biomedical applications, like any pharmaceutical drug,
have power in numbers. The ultimate goal is to have a high accumulation in the affected
area without using high dosages that may affect the patient negatively. This can be
accomplished in magnetic nanoparticle composites by designing ligands that increases
the lifetime of the particles in the body,131 as well as taking advantage of the particles’
surface139 to target certain cells by exploiting over expressed receptors.
To improve circulation of the material in the body, nanoparticles must be
protected from nonspecific reactions from proteins in the biological environment. Using
ligands with multiple anchoring groups has been reported for stabilizing quantum dots157
and gold nanoparticles158 in biological conditions. Bagaria et al. found that grafting a
sulfonated block copolymer onto the surface of 2-aminopropyl triethoxy silane (APTES)
modified magnetic nanoparticles provided colloidal stability in brine solutions at 90 °C
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over 30 days. They report this was due to the multiple grafting points provided by the
number of sulfonated groups along the polymer chain to the APTES on the nanoparticle
surface.159,160

Dr.

Riffle’s

research

group

at

Virginia

Tech

synthesized

a

heterobifunctional PEO with a functional anchoring group comprised of three
phosphonate zwitterions. They were able to produce extended colloidal stability in
phosphate buffer saline (PBS) over 24 hours, which was not seen in heterobifunctional
PEO modified with a single phosphonate zwitterions.161 Ligands with multiple robust
anchoring groups, i.e. catechols, for iron oxide nanoparticles have also shown improved
colloidal stability.162 In fact, Saville et al. reported that increasing the number of
nitroDOPA groups, from one to three, per PEO chain increases the colloidal stability of
the magnetic nanoparticles in protein rich environments significantly.131
Designing ligands for biological targeting imaging applications can be exhaustive
and the reactions can be inefficient. The synthesis of these ligands generally requires
harsh solvents that must be completely removed before any biological interaction. “Click
chemistry” was designed to bring two groups together to create a strong and stable
linkage. Originally developed for facile protein modification, it was later used to
efficiently modify polymers. The most common of the “click reactions” is the Huisgen
1,3-dipolar cycloaddition between an alkyne and an azide. Na et al. have demonstrated
this by modifying polyacrylic acid (PAA) with methyl-terminated and azide-terminated
PEO, using multiple catechols (~6) to provide enhanced stability at different pH and salt
concentrations. The particles also provided surface functionality through the azide that
was reacted with alkyne-modified rhodamine B using “click chemistry.163”
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Reported is the synthesis and characterization of a magnetic nanoparticle
composite comprised of an iron oxide core and a functional polyethylene oxide (PEO)
scaffold with enhanced stability in biological environments that can be tailored for a
variety of biomedical applications using “click chemistry.” The scaffolding was created
by first linking a specially designed heterobifunctional PEO to PAA and then modifying
the newly formed brush with nitroDOPA for anchoring to the magnetic nanoparticle
surface. To illustrate the enhanced stability of the aforementioned particle, it was
submitted to a variety of simulated biological environments at body temperature and
compared to a mono-anchored particle of similar size and composition. The multianchored particles were also modified with different functional moieties to exhibit the
flexibility and customization of the surface for a variety of theranostic applications.
4.3. EXPERIMENTAL
4.3.4. Modification of Protected amine-PEO with alkyne
The procedure used is based on previous work done by Kim et al.116 Protected
Amine-PEO-OH(2.0 g, 0.33 mmol) and sodium hydride (32 mg, 1.32 mmol) was charged
to a 100 mL round bottom flask equipped with a stir bar. The flask was the sealed with a
septum and purged with nitrogen for 30 seconds. THF (40 mL) was added via syringe
and the reaction was brought to 0 °C using an ice bath. Propargyl bromide (0.15 g, 1.32
mmol) was slowly added via syringe over 30 minutes. All the reactants were left to stir
for another 30 minutes at 0 °C. The flask was then removed from the ice bath and
brought to room temperature to react for 24 hours. The final solution was filtered to
remove excess sodium hydride and precipitated with DEE twice to collect polymer.
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1

HNMR (300 MHz, CDCl3), δ (ppm): 3.56 (m, CH2-CH2-O), 2.43 (s, -O-CH2-

C≣CH), 4.19 (s, -O-CH2-C≣CH), 2.75 (m, (TMS)2-N-CH2-) 1.19 (m, TMS).
4.3.5. Deprotection of amine-PEO-alkyne
The deprotection of the amine was accomplished by dissolving the polymer (1.8 g,
0.30 mmol) into methanol and then slowly adding 20 drops of a 1 M HCl solution and
stirring over night under a nitrogen head. The product was precipitated with DEE (2x)
and the solid was collected. The cleavage of the bis(trimethylsilyl) (BTMS) group was
confirmed by HNMR.
1

HNMR (300 MHz, CDCl3), δ (ppm): 3.65 (m, CH2-CH2-O), 2.44 (s, -O-CH2-

C≣CH), 4.19 (s, -O-CH2-C≣CH)
4.3.6. Modification of poly(acrylic acid) with amine-PEO-alkyne
In a 100 mL round bottom flask equipped with a stir bar and condenser, aminePEO-alkyne (0.8 g, 0.14 mmol) was dissolved in 40 mL of THF and brought to 0 °C.
DCC (0.03 g, 0.14 mmol) was then added and stirred for 30 minutes under constant
nitrogen purge. Finally PAA (0.05 g, 0.03 mmol) and DMAP (0.003 g, 0.03 mmol) was
added and brought to reflux at 70 °C for 2 days. After two days, the solution was filtered
to remove any undissolved reactants and precipitated with DEE. The polymer was then
dissolved in DCM and precipitated with DEE (2X) and the final solid was characterized
by 1HNMR.
1

HNMR (300 MHz, CDCl3), δ (ppm): 3.56 (m, CH2-CH2-O), 2.43 (s, -O-CH2-

C≣CH), 4.20 (s, -O-CH2-C≣CH), (b, 1.20-2.25, PAA)
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4.3.7. Modification of PAA-PEO-alkyne with NitroDOPA
To a 100 mL flame dried, round bottom flask equipped with a stir bar, PAA-PEOalkyne (0.4 g, 0.0015 mmol) was dissolved in DMF and brought to 0 °C using an ice bath.
EDC (0.002 g, 0.013 mmol) and TEA (2.0 µL, 0.015 mmol) were both added while
purging with nitrogen and stirred at 0 °C for 30 minutes. The final reactants, nitroDOPA
(3.0 mg, 0.012 mmol) and DMAP (0.3 mg, 0.003 mmol), were added under a constant
nitrogen purge and stirred for another 30 minutes. Finally, the reaction was removed from
the ice bath and brought to 80 °C for 5 days. The purification was accomplished by
bringing the reaction to room temperature and filtering out any solids. The polymer was
then precipitated with DEE and the solid was dissolved in chloroform. Vacuum filtration
was then used to remove any excess nitroDOPA. The filtrate was collected and polymer
was collected by precipitation in DEE (2x). The polymer was then dissolved in DI water
and dialyzed using 1000 g mol-1 MWCO dialysis membrane. Product was confirmed by
1

HNMR and FTIR.
1

HNMR (300 MHz, CDCl3), δ (ppm): 3.62 (m, CH2-CH2-O), 2.43 (s, -O-CH2-

C≣CH), 4.19 (s, -O-CH2-C≣CH), (b, 1.20-2.25, PAA). nitroDOPA: 6.12 and 6.70 (s, CH
in ring).
4.3.8. Modification of Magnetic Nanoparticles with Polymer
NitroDOPA-PAA-PEO-alkyne (0.2 g, 0.0007 mmol) was dissolved in 10 mL of
chloroform. 7.2 nm particles in hexane (1 mL, 2 mg of Fe3O4 mL-1) were slowly added
over 30 minutes while using sonication. Once all the particles were added, the solution
was stirred overnight. The particles were then precipitated with hexane and dispersed in 5

83

mL of ethanol to dissolve any of the displaced oleylamine and precipitated with hexane to
collect the polymer-modified particles. The particles were then dispersed in DI water and
dialyzed for 2 days.
4.3.9. Cell Viability Studies
Materials used for cell viability were as follows: 96 well plate was purchased
from BD biosciences, CCD18-Co cells, L929 cells (ATCC® CCL-1TM) and EMEM (302003TM) where purchased from ATCC and used as received, phosphate buffer solution
from Sigma Aldrich was autoclaved prior to usage, trypsin-EDTA (25-053-Cl) and
trypsin Blue (25900-Cl) were purchased from Cellgro and used as received.
The cytotoxicity of the modified magnetic nanoparticles particles was done by
adding 200 µl of L929 cells (4.5 x 105 cells per well)/ CCD18-Co (2 x 104 cells per well)
into a two 96 well plate and incubated for 24 hours at 37 °C, 5% CO2 atmosphere. The
particles were then plated, in quadruplicate by adding 1, 2, 3, 4, 5, 6, 8 µl and a control
with no particles. One plate was incubated with particles for 24 hours and the other was
incubated for 48 hours before analyzing. MTS assays were preformed using a modified
protocol suggested by Promega. The plates were washed with PBS twice followed by the
addition 100 µl of media before 20 µl of CellTiter 96® AQueous One Solution Reagent
was added to each well. The plates were then incubated at 37 °C at 5% CO2 atmosphere
for 4 hours before absorbance at 490 nm was read using 96-well plate reader.
4.3.10. Modification of particles with Azido-Cy5.5 Dye
To 10ml of DI water, 0.5 mL of modified particles (0.7 mg of modified particles
mL-1) was added. The azido-Cy5.5 (0.003 mmol) was added to solution followed by
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CuSO4 (0.013 mmol) and sodium ascorbate (0.003 mmol). The reaction was then covered
with foil and stirred at 28 °C for 12 hours. The particles were then removed from heat
and dialyzed for 3 days against DI water.
4.4. RESULTS AND DISCUSSION
A heterobifunctional PEO was synthesized using a combination of ring opening
polymerization and end group modification, as portrayed in Figure 4.1. Using potassium
bis(trimethylsilyl)amide solution has been used as an anionic initiator, to ring open
elthylene oxide to produce PEO with a protected amine at one end and a free alcohol at
the other.164 NMR displayed methylene shifts of PEO at 3.56 ppm and the adjacent
hydrogen to the protected amide group at 2.75 ppm. Using propargyl bromide in the
presence of NaH, the free alcohol on the PEO was substituted with propargyl end group,
indicated by peaks 2.43 and 4.19 ppm in the 1HNMR. Then using a 1M HCl solution, the
TMS that was protecting the amine was removed, which was seen from the absence of
the shift at 1.19 ppm.
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Figure 4.1. Schematic of synthesis and end group modification to yield
heterobifunctional PEO (amine-PEO-alkyne)
The heterobifunctional PEO prepared was now primed to react with the
carboxylic acids of PAA, as presented in Figure 4.2. Using DCC coupling, the aminePEO-alkyne was reacted with the carboxylic acids of PAA, targeting a 5:1 ratio of PEO
to PAA chain.163 A broad peak at 1.20-2.25 ppm confirmed the presence of PAA after the
reaction. The peaks of the propargyl end group were still present at 2.43 and 4.20 ppm.
Using the ratio of integrals between the α hydrogen of the PAA (25H) and the single
proton on the alkyne terminus of the PEO (1H) the grafting density on the PAA was
found to be approximately 6 chains of PEO per PAA. The FTIR spectrum in Figure 4.3
also confirms the presence of the alkyne at 3237 cm-1, the carboxyl stretch at 1648 cm-1
and the amide stretch at 1531 cm-1.
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Figure 4.2. Schematic of step taken to synthesize multi-anchored particles. 1)
Modification of PAA with amine-PEO-alkyne. 2) Modification of PAA-PEOalkyne with nitroDOPA. 3)Particle modification with multi-anchored particles
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Figure 4.3. FTIR spectra of PAA (red) and PAA-PEO-alkyne (blue). Peak at 1728 cm-1
is attributed to carboxyl from PAA, and the peaks at 1648 and 1531 cm-1 are
attributed to the carboxyl amide bond between amine-PEO-alkyne.
Using EDC coupling, PAA-PEO-alkyne was modified with nitroDOPA, in a 10:1
ratio. An excess of nitroDOPA was used to ensure there is increased anchoring when
modifying the iron oxide nanoparticles. NitroDOPA-PAA-PEO-alkyne, after purification,
was immediately dissolved in chloroform and used in the modification of nanoparticles.
Using sonication while slowly adding particles to the polymer solution helps facilitate the
ligand exchange and ensure maximum surface coverage. The transfer of particles to water
was a good indication of a successful modification. Using DLS and TEM, surface
modification was confirmed by an increase in hydrodynamic radius and polymer halo
around the dense magnetic nanoparticle, Figure 4.4. The surface coverage of polymer on
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the particle was determined by TGA, Figure 4.5. There was an 81.3% weight loss, from
372 °C to 415 °C, from the nitroDOPA-PAA-PEO-Alkyne (9.49 mg).

Figure 4.4. TEM micrograph (left) of multi-anchored particles and DLS (right) of the
modified particles in DI water.
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Figure 4.5. TGA thermogram of multi-anchored magnetic nanoparticles, 81.3% weight
loss.
The particles were analyzed with FTIR to corroborate the DLS and make sure it
had the desired surface functionality. As seen in Figure 4.6, the peak at 3237 cm-1
confirms the presence of the alkyne165 as well as the presence of carboxylic acids from
PAA (1711 cm-1) and amide linkages (1643 and 1561 cm-1) from the nitroDOPA and/or
PEO to the PAA.
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Figure 4.6. FTIR spectrum of multi-anchored particles. A) Alkyne group on the surface
of the particle. B) Carbonyl stretching of PAA (1711 cm-1). C and D) Amidecarbonyl stretch (1643 and 1561 cm-1) indicating modification of PAA.
The particles were then subjected to a series of biological simulations to establish
if the multi-anchoring enhances the stability compared to mono-anchored modified
particles, which are previously reported. PBS is a buffer solution that matches the ionic
strength of the human body and is commonly used in biological research. Each particles
solution (0.1 mg/mL) was titrated with 10, 30, 50 and 100% by volume of 1 N PBS
solution and the hydrodynamic diameter was observed using DLS. The results shown in
Figure 4.7 show the enhanced stability of the multi-anchored particles compared to the
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mono-anchored. At 100% by volume of PBS with the mono-anchored particles there is an
obvious decrease in original particles size and the formation of large clusters greater than
1000 nm. No visible effect on size was observed for the multi-anchored particles.

Figure 4.7. Stability studies comparing mono and multi-anchored particles. A) DLS of
mono-functional particles in 50% by volume PBS at 37 °C; B) DLS of multifunctional particles in 50% by volume PBS at 37 °C; C) DLS of mono-anchored
particles titrated with PBS from 0-100% by volume; D) DLS of multi-anchored
particles titrated with PBS from 0-100% by volume;
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The human body operates at temperatures greater than room temperature, so using
DLS, the hydrodynamic diameter of the particles was measured in a 50% by volume of
PBS (1N) at the average human body temperature, 37 °C, for 5 minutes. In Figure 4.7,
the multi-anchored particles show no change in hydrodynamic diameter in this simulated
environment. The mono-anchored size distribution, although stable in the same ionic
environment, broadens with an increase in temperature. The multiple nitroDOPA groups
increase the amount of interactions with the surface of the iron oxide nanoparticles
keeping the steric interactions intact that are involved in keeping the particles discrete
and stable.131
Table 4.1 Presents the results of the time dependence studies done in a 50% FBS in
magnetic nanoparticles solution (v/v).

DI Water
50% FBS
50% FBS at 70 °C
50% FBS over 24hrs*

Mono-anchored
(d.nm)
118.90
121.00
122.40
203.65±30.14

Multi-anchored
(d.nm)
105.71
100.79
107.80
95.73±21.85

*average hydrodynamic diameter over 24 hours; measurements taken every 12 minutes

Time dependence studies, Table 4.1 were done in FBS, fetal bovine serum, on
both the mono and multi-anchored particles to see how their stability compares to each
other in a high temperature, protein rich environment. One milliliter of each particle
system, each with a concentration of about 1 mg of multi-anchored particles mL-1 in DI
water, was added to a cuvette and 500 µL of FBS (0.125m mg of hemoglobin) was
titrated into the cuvette and vortexed for 20 seconds. The particles were first measured at
room temperature and the mono-anchored particles had approximately a 3nm increase in
diameter. The multi-anchored particles had a slight decrease in hydrodynamic diameter of
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about 5 nm. The hydrodynamic diameter of the particles was measured at 70 °C and only
a slight increase in particles size was observed; 1.4 nm for the mono-anchored and 7.1
nm for the multi-anchored. The samples were then measured again at 70 °C every 12
minutes for 24 hours. The mono-anchored particles’ average hydrodynamic diameter
over the 24 hours almost doubled in size from 122.4 nm to 203.56 nm. The size increase
is indicative of clustering that can occur when ligands are displaced by proteins in the
environment, decreasing the steric hindrance. This phenomenon was not observed for the
multi-anchored particles, the average size over 24 hours was measured to be 95.73 nm.
Statistical analysis, using one way ANOVA, showed there was a statistically significant
difference between the average sizes measured for the mono and multi-anchored particles
(p<0.0001, n=108). This data shows how crucial multiple anchoring groups are for
stability in harsh biological environments.
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Figure 4.8. Cell viability of L929 cells after exposure with multi-anchored particles for
24 and 48 hours at different concentration of iron. (mean± standard dev.; n=3)
When synthesizing materials for biomedical applications, evaluating of its toxicity
is very important.166,167 An MTS assay was done on the muti-anchored particles to
determine if there is a negative cytotoxic effect. MTS assay utilizes (3-[4,5dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) dye that is processed into
formazan by living cells that has an absorbance at 490nm that can be quantified.168 The
viability is determined by counting the live cells incubated with the particles and
comparing them to the number of proliferated cells in the control, cells that have not been
exposed to the multi-anchored magnetic nanoparticles. L929 mouse fiberblast cells are
used in many publications to test the cytotoxicity of magnetic nanomaterials.169-173
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Figure 4.8 shows the cell viability results of incubated multi-anchored particles
over 24 and 48 hours at different concentrations of iron in media with L929 cells, ranging
from 8 to 63 mg mL-1 and MTS assay was done to quantify the live cells. The particles
that were incubated for 24 hours showed a decrease in viability compared to the control,
of approximately 25% on average, for all concentrations. Statistical analysis using a oneway ANOVA showed that there was no statistically significance difference between the
mean of the control and all the concentrations tested (p=0.18). This indicates that there is
no significant effect of concentration on the cytotoxicity of the multi-anchored magnetic
nanoparticles. The L929 cells were also exposed to the multi-anchored nanoparticles for
48 hours to see if there may be a time dependence toxicity that could not be seen in the
24 hours study. Statistically, ANOVA analysis showed that there was no statistically
significant difference between the means of the control and the different concentrations
over 48 hours (p=0.42). In fact, cell growth was observed after 48 hours of incubation.
Below, in Figure 4.9, micrographs of the L929 cells with different concentrations of
multi-anchored nanoparticles were taken after 24 hours of treatment. In Figure 4.9,
optical micrographs of the cells showing the control and the cells incubated with 63 mg
ml-1 of Fe3O4 nanoparticles particles after 24 hours. Healthy cells, circled in green in
Figure 4.9 (A), are extended and attached to the bottom of the cell well plate. Dead cells
are detached from the cell well plate and ball up; an example of a dead cell is circled with
a red circle in Figure 4.9 (B). Optical micrographs of the cells after incubated for 48
hours are displayed in Figure 4.10 to show there was no visible difference between the
control and cells exposed to 63 mg ml-1 Fe3O4 nanoparticles.
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Figure 4.9. Micrographs of cells incubated with multi-anchored magnetic nanoparticles
after 24 hours. A) Control, B) 63 mg of Fe3O4 mL-1, respectively. All scale bars
are 100 micrometers. Green circle shows an example of a living cell and red
circle shows a dead cell.

Figure 4.10. Micrographs of cells incubated with multi-anchored magnetic nanoparticles
after 48 hours. A) Control, B) 63 mg of Fe3O4 mL-1, respectively. All scale bars
are 100 micrometers. All scale bars are 100 micrometers. Green circle shows an
example of a living cell and red circle shows a dead cell.
To demonstrate the availability of the surface to be functionalized with an azidoconjugated molecule, an azido-Cy5.5 was “clicked” on to the surface of the polymermagnetic nanoparticle complex in water at 28 °C for 12 hours in the absence of light.
Sodium ascorbate was used to reduce copper (II) sulfate in solution to catalyze the

97

reaction and yield the 1,4 conformation of the 1,2,3, triazole.109 Cy5.5 is an example of a
near infrared (NIR) dye that has an emission range of (700-1000 nm).174 After dialysis for
3 days, the modified particles were analyzed using photoluminescence by exciting at 650
nm and observing an emission peak at 705 nm, Figure 4.11. The multi-anchored particles,
not modified with Cy5.5, were also excited at the same wavelength, but no emission was
observed. A NIR dye was chosen to modify the particles because it can easily be detected
with photoluminescence and it shows that these particles can be modified with a
molecule that is used.

Figure 4.11. Photoluminescence of multi-anchored particles before and after being
modified with Cy5.5 using “click chemistry.”
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4.5. CONCLUSIONS
The goal of this work was to produce a PEO ligand to improve the stability of
magnetic nanoparticles for biomedical applications. This was accomplished by using
poly(acrylic acid) as the spine to hold multiple anchoring groups per PEO chain. Using
anionic polymerization of ethylene oxide, initiated by potassium bis(trimethylsilyl)amide
solution, and end group modification a heterobifunctional PEO was synthesized with an
alkyne on one end that can easily functionalized using “click chemistry” and an amine
that could be reacted with the carboxylic pendants of poly(acrylic acid). The use of
nitroDOPA gave a stable anchor to the iron oxide surface. Increased stability in extreme
biological environments was demonstrated by comparing it to mono-anchored particles of
a similar nature in ionic and protein rich solutions. Not only is this polymer-magnetic
nanoparticle complex stable in harsh biological environments, but toxicity studies on
these particles show statistically insignificant decrease in viability as a function of
concentration and incubation time, up to 48 hours. The functionality of the surface
incorporated in the design of this stabilizing ligand was displayed by successfully
modified with a near-IR dye (Cy5.5), commonly used for biological imaging, by “click
chemistry.”
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CHAPTER 5. VERSATILITY OF A MULTI-ANCHORED HETEROBIFUNCTIONAL
POLY(ETHYLENE OXIDE) MODIFIED MAGNETIC NANOPARTICLES
INTRODUCTION
When designing the polymer-magnetic nanoparticle complex described in
Chapters 3 and 4, the initial application in mind was targeted magnetic hyperthermia for
the treatment of cancer. When discussions arose with different research groups in fields
of biology and bioengineering, the desire for magnetic nanoparticles suspended in
aqueous media that can be tailored to their specific applications was a problem they were
not equipped to solve. The particles synthesized in the aforementioned in Chapters 3 and
4, originally designed for targeted magnetic hyperthermia of cancer, were now needed for
other studies, Figure 5.1, involving alternative antibiotics,175 effects of nanoparticles on
biofilms,176 and a new approach of thernostics for cancer early detection and treatment.177
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Figure 5.1. Schematic summarizing the flexibility of the heterobifunctional PEO
scaffolding used to modify magnetic nanoparticles. A) magnetic nanoparticle
modified with alkyne-PEO-nitroDOPA, B) micrograph of clustered E. coli using
magnetic nanoparticles functionalized with Tr-32, C) 3D fluorescent imaging of
biofilms treated with magnetic nanoparticles with Cy5.5 dye, and D) Chelated
64
Ga ligand used to modify magnetic nanoparticles for SPECT/MR imaging.
BACTERIAL AGGREGATION AND TREATMENT USING MAGNETIC
HYPERTHERMIA
Dr. Tzeng’s group in the biology department at Clemson University were working
on clustering different types of dangerous bacteria that is commonly found in an infected
colon and applying an alternating magnetic field to disrupt their growth. They needed
magnetic nanoparticles coated with a tri-carbohydrate that will actively target the
bacteria’s surface. Carbohydrates, linked to nanoparticles, have been found to bind to
bacterial surface receptors, called adhesins, for use in detection and treatment of bacterial
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infections.121 The mono-anchored magnetic nanoparticles with an alkyne surface,
described in Chapter 3, was modified with an azido tri-saccharide using “click chemistry.”
The solution was then dialyzed for 3 days before given to Dr. Tzeng’s research group
where they then used them to cluster E. coli K99 bacterial cells.
Tr 32: Neu5Ac(a2-3)Gal(b1-4)Glcb-Sp
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Molecular Weight: 702.62

O
OH

HO
O

OH

O

H
N

OH
O

O
O

O

HO
HO

CH3

O
OH

HO

N3

Figure
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coli O157:H7. As seen in Figure 5.3HO(C), there was no aggregation observed. When the
Tr-32 modified particles were added to E. coli K99 the bacterial cells were aggregated to
structures over 100 µm larger, Figure 5.3 (D). A colony forming unit (CFU) assay was
used to quantify the bacterial cells before and after treatment with nanoparticles.175 The
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data was conclusive, Figure 5.3, showing no significant reduction of CFU for the monoanchored particles and a one-log reduction of CFU when the E. coli K99 cells were
targeted and agglomerated.
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Figure 5.3. Fluorescence (left column) and phase-contrast (right column) microscopy of
A) E. coli K99 in PBS, B) E. coli K99 with mono-anchored particles
(unmodified), C) E. coli O157:H7 with Tr-32 modified particles, D) E. coli K99
with Tr-32 modified particles. All scale bars are 100µm.
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Figure 5.4. E. coli treatment with mono-anchored particles (unmodified) and Tr-32
modified particles. Data represented as Mean ± SD (n=3)
The E. coli K99 bacteria treated with the Tr-32 modified magnetic nanoparticles
were characterized in an alternating current (AC) calorimeter to use magnetic
hyperthermia to destroy the bacterial cells. Each sample was placed inside a temperature
controlled water bath (45 °C) inside of a 5-turn, 2” in diameter copper coil. At 207 KHz
and 480 A, we were able to produce an alternating magnetic field of 32.4 to 38.8 KAm-1.
Initial experiments were done at 37 °C to emulate body temperature but because the
concentration of magnetic nanoparticles was low, for the max field and frequency, the
water dissipated the energy and temperature at which the bacteria will die could not be
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reached. The temperature was then increased to 45 °C for all measurements so the
amount of energy needed to increase the temperature for the hyperthermia treatment of
the bacterial cells, at 47°C, could be accomplished. The samples were put in the
alternating magnetic field for 5, 10, 15, 30 and 60 minutes. CFU assay was then used to
quantify and compare the treatments of different lengths. In Figure 5.4, the histogram
shows that there was no significant change was observed in the control in all experiments.
The mono-anchored particles exposed to a field for up to 15 minutes showed no
significant loss of colony forming units. Thirty and sixty minute treatments yielded a onelog reduction in CFUs. All the samples were equilibrated to 45 °C before the magnetic
field was applied, so the magnetic nanoparticles had to increase the temperature of the
environment above temperature set by the water bath to have significant cell death. The
particles modified with Tr-32 after 5 and 10 minutes in the magnetic field doubled the
CFUs, which is hypothesized to the particles breaking up the aggregates from the motion
of the particles in the field. After 15 minutes of treatment, there was a one log reduction
and a two log reduction after 30 and 60 minutes which is a statistically significant
decrease in CFUs,(p<0.0001). The two log reduction of CFUs for E coli K99 are on the
same order of a many disinfectants that claim to kill 99.999% of bacteria. The efficiency
of targeting and killing bacteria, shown with these initial hyperthermia results, is proof
that these polymer-magnetic nanoparticle complexes are a viable alternative to antibiotics.
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Figure 5.5. Hyperthermia treatment of E. coli with mono-anchored particles
(unmodified) and Tr-32 modified particles. Data represented as mean ± SD
(n=3) (p<0.001)

107

Figure 5.6. A) MTS assay of mono-anchored nanoparticles in human colon cells
(CCD18-Co). B) MTS assay of Tr-32 modified nanoparticles in human colon
cells (CCD18-Co).
MTS assays were performed on the mono-anchored magnetic nanoparticles and
Tr-32 modified nanoparticles in human colon cells (CCD18-Co). This specific cell line
was chosen because of where the targeted bacteria are located. In Figure 5.6 (A), there
were no significant cytotoxic effects of the unmodified particles to the colon cells. After
the particles were modified with Tr-32, there were still no significant cytotoxic effects
observed of the nanoparticles, Figure 5.6 (B).
The initial work reported in this section shows that targeting, clustering, and
hyperthermia of a specific type of E. coli is possible if time in the magnetic field is long
enough. This can be improved by increasing the concentration and/or the size of the
magnetic particles to increase the size of the clustering of the bacterial cells and the
amount of heat generated to induce cell death. In the future work it will also be important
to determine the ideal number of tri-saccharides per particle, not only for Tr-32 but other
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tri-saccharides used for targeting specific bacteria, that is needed for clustering for more
efficient particle design.
INTERACTIONS OF MAGNETIC NANOPARTICLES IN BACTERIAL BIOFILM
Nanoparticle research is important for the advancement in biomedical
applications but there is also a concern on the impact of these materials on the
environment. Biofilms are an important source of nutrients for ecosystems and is the base
food supply for a lot of organisms.178 Biofilms can contain Legionella bacteria found in
industrial settings that is very harmful to humans because of potential outbreak of
Legionnaires’ disease, so prevention and treatment of biofilms is very important.179
Legionnaires’ disease is a combination of diseases involving pneumonia and flu-like
illness that makes it difficult to diagnose without microbiological testing.180 In fact, it is
such a problem in some areas of the world that statistical and impact research is being
published this year for incidences that occurred in Glasgow, UK and Christchurch, New
Zealand.181
Dr. Tamara McNealy’s research group at Clemson University is currently
studying the effects of different types of metal nanoparticles on Legionella pneumophila
biofilms that are found in natural and man-made environments.182 Raftery et al.
characterized Legionelle pneumophila biofilms after they have been subjected to gold,
platinum, silver and iron oxide nanoparticles. They discovered that the platinum and iron
oxide nanoparticles had the largest reduction in the biofilm after 48 hours of exposure by
analyzing and comparing the surface roughness of the metal nanoparticle treated and a
control.176
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They were able to conclude that there was an adverse effect, but they were not
able to visualize where and how the particles interact with the biofilms. Their group
approached needed a water-soluble magnetic nanoparticles with a fluorescent dye so a
Leica GSD microscope could be used to observe where polymer-magnetic nanoparticles
settle in a biofilm. Polymer-magnetic nanoparticle complexes synthesized in Chapter 4
was modified with and azido Cy5.5, as described in section 4.3.10. Cy5.5 is a near IR dye
that emits at 707 nm, which was far enough down the visible light spectrum from the
Syto11 green fluorescent nucleic acid stain used for observing the biofilm that emits at
527 nm.
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Figure 5.7. 3D Micrographs of L. pneumophila before and after treated with
nanoparticles. A) Confocal micrograph of biofilm control. B) Confocal
micrograph of biofilm treated with 1 µg of Fe/L of Cy5.5 modified magnetic
nanoparticles. C) GSD micrograph of control. D) GSD micrograph of biofilm
treated with 1 µg of Fe/L of Cy5.5 modified magnetic nanoparticles.
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Figure 5.8. A) Biomass, B) Thickness, and C) Roughness analysis of biofilms before and
after Cy5.5 particles were added. Data represented as Mean ± SD (n=3)
There is definite disruption in the biofilm, as seen in Figure 5.7 (B), as compared
to the control, Figure 5.7 (A). There is a visible decrease in the bio-volume after
treatment with the Cy5.5 modified magnetic nanoparticles. Characterization of the
control biofilm and the biofilm treated with particles was analyzed for change in biomass,
thickness, and roughness. There was a statistically significant decrease in biomass after
the addition of nanoparticles, (Figure. 5.8 (A), p=0.008, t-test). There was also a
significant decrease in the thickness of the film, Figure 5.8 (B), confirming the loss of
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height of biofilm due to the magnetic nanoparticles (p=0.021, t-test). Finally roughness
was quantified, Figure 5.8 (C), and the results show an almost 40% increase compared to
the control. Figure 5.8 (C) and (D) are before and after particle addition, respectively.
The image for the control was taken after being exposed to specific wavelength and then
scanned to read the excitation. Figure 5.9 is an overlayed 3D image that was excited at
about 508 nm to image the biofilm (green) and then was excited at about 673 nm to
image the Cy5.5 modified magnetic nanoparticles (red). The magnetic nanoparticles are
being internalized and dispersed into the biofilm; because they are discrete magnetic
nanoparticles modified a water-soluble ligand. The structure allowed the nanoparticles to
enter gaps in the biofilms and destabilize the structure of the matrix. This phenomenon is
difficult to observe with fluorescent confocal microscopy. This initial work will be able
to give more information about how these nanoparticles are interacting once inside of the
matrix that will help understand the mechanism used for biofilm reduction and can help
develop new materials that will remove contaminating biofilms.176
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Figure 5.9. Side profile of GSD image of biofilm (green) modified with Cy5.5 magnetic
nanoparticles (red)
MULTIFUNCTIONAL DIAGNOSTIC PROBE FOR SPECT/MR IMAGING
Improving the efficiency of materials used for theranostics is very important for
early detection and treatment, especially for many types of cancers that can metastasize
rapidly. Dr. Urs Häfeli from the University of British Columbia proposed that combining
multiple imaging techniques, magnetic resonance imaging (MRI) and single-photon
emission computed tomography (SPECT), can give provide more information to medical
practitioners to better diagnose their patients.177 SPECT requires radiotracers (radioactive
iodine, indium and technetium) in very low concentrations for a measureable signal, but
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cannot provide anatomic information because of its poor special resolution. To detect the
locations of abnormalities, MRI is a much better tool for examining tissue because it uses
contrast agents, such as magnetic nanoparticles, that magnetically relax as a function of
its molecular environment.183 So combining these two great techniques will require a
material that can facilitate radiotracers for high sensitivity and superparamagnetic
nanoparticles for high spatial resolution.
The polymer-magnetic nanoparticles that have been described in Chapter 4 were
the perfect solution for creating a multifunctional diagnostic probe. Some of the multianchored magnetic nanoparticles, Chapter 4, was shipped to their laboratories in
Vancouver and they were able to successfully modify the particles with 67Ga.
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Figure 5.10. Schematic 1,4,7-triazacyclononane-1,4,7-triacetate (NOTA) ligand that is
commonly used to chelate 67Ga radiotracer.
The functionalization of the multi-anchored magnetic nanoparticles with a radio
tracer was accomplished by first modifying the particles with an azide ligand,184,185
Figure 5.8, using copper(II) sulfate and sodium ascorbate to create copper(I) catalyst in
situ, that has the ability to chelate rare earth metals. After the particles were modified,
they were dialyzed against water for 2 days and then lyophilized. The particles were then
dispersed in water and mixed with 67GaCl3, shaken for twenty minutes, centrifuged with a
30 kDa MWCO filter, washed, and then collected. Based on the number of the
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67

Ga

present, there was an average of 68% labeling efficiency. This is very new data and
repetition of modification should be done to ensure labeling of 67Ga. Once these materials
have been thoroughly characterized, their biodistriubtion and ability to monitor
biomolecular processes should be studied to see how well these particles survive in situ
using mice models.
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CHAPTER 6. FUTURE WORK
Magnetic nanoparticles are one of the most fascinating materials to study because
their applications are limitless. Designing different polymer surfaces for magnetic
nanoparticles can provide a very useful tool for therapeutics and diagnostics that can be
tailored to individual patient’s need. The original frustration of creating made to order
heterobifunctional PEO for magnetic nanoparticles, with different surface chemistries to
further research in different research groups brought about the need for creating a
functional scaffolding that could create a batch of universal biologically stable magnetic
nanoparticles. This universal particles design using PEO has great potential for
fundamental research in magnetic nanoparticles in biomedical applications. The control
of molecular weight and end group functionality inherent in anionic ring opening
polymerization of ethylene oxide will allow researchers to study the effect of molecular
weight and surface chemistry on biological phenomena, i.e. targeting, heating efficiency,
and biodistribution.
It has been shown that the design and synthesis of a universal ligand is possible
on small scales because of limitations of reaction times and cost of materials. For these
universal magnetic nanoparticle complexes to become a viable alternative to synthetic
drugs already on the market, scaling up is necessary. So, designing new initiators that can
efficiently polymerize ethylene oxide to provide the desired functionality and molecular
weight will improve yields because there will be a decrease the number of end group
modifications. One possible idea is to synthesize an initiator from propargyl alcohol, or
amine, where the terminal carbon-hydrogen bond (C-H) of the alkyne is protected. This
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can be done using a trimethylsilyl group, to protect the acidic proton of the alkyne from
the caustic environment generally needed to create the anion that initiates the ring
opening of ethylene oxide, Figure 6.1. Anionic ring opening polymerization of ethylene
oxide using this method will allow for the production of various molecular weights with
narrow distributions.
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Figure 6.1. Proposed anionic ring opening polymerization of ethylene oxide using a
protected propargyl alcohol as an initiator.
Once the process of synthesizing specialized heterobifunctional PEO with an
alkyne on one end for easy functionalization and a catechol on the other end for strong
binding to metal nanoparticles is streamlined, a large library of polymer-magnetic
nanoparticle complexes of various molecular weights and metal core diameters is
possible in the foreseeable future. Aliquots from this library could then be easily
modified due to the alkyne surface, using “click chemistry,” with a variety of functional
moieties specific to the desired application. Some examples of functional moieties that
can be used are fluorescent dyes for imaging,155 rare earth metals for temperature
sensing,186 active targeting drug delivery,187 radiotracers to improve diagnostic
techniques,148 and/or a combination of them to create a multifunctional device, a
schematic of this multifunctional device is shown in Figure 6.2.108
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Figure 6.2. Magnetic nanoparticle functionalized with a variety of functionalities on the
same nanoparticle. From top to bottom: moiety that can chelate different metals,
folic acid to target overexpressed folate receptors, and Cy5 NIR dye that can be
used for imaging through human tissue.

Magnetic nanoparticles that are modified with multiple binding groups per
polymer chain have been shown to increase the steric stability in biological environments.
They have been synthesized in a variety of ways using multi-functional initiators or
modification of PAA to make brushes.131,163 Atom transfer radical polymerization
(ATRP) could be used to copolymerize a heterobifunctional PEO analogue with an
alkyne on one end and a methacrylate on the other with a catechol methacrylate. This
approach can synthesize a block copolymer that is water-soluble, has a surface that can
be functionalized using click chemistry, and has a catechol that can strongly interact with
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metal oxide surfaces, schematic in Figure 6.3. The heterobifunctional analogue would be
synthesized by anionic ring opening polymerization of ethylene oxide using a protected
propargyl alcohol. Then though end group modification, it will be modified with a
methacrylate using methods discussed in section 2.10.4. The dopamine analog would first
be protected as an acetonide188 and then reacted with methacroyl chloride via a
substitution reaction. Once the analogs are synthesized, using copper(I) chloride and 2,2’
bipyridyl (Bipy) to radically polymerize them together and then the catechol could be
deprotected with acid and then magnetic nanoparticles could be modified. This is another
example of a type living polymerization that can yield narrow molecular weight polymers
with control of each block length189 that can be used to study the optimal ratio of PEO to
catechol needed for creating biologically stable magnetic nanoparticles.
O
O

HO

OH

O

O

n

O
O

O

O
O n
Br

O

O

Cu(I)Cl
Bipy

O

O

O
O

O
Cl

m

p

Figure 6.3. Schematic of ATRP polymerization of PEO-alkyne and catecholmethacrylate block copolymer.

Well characterized materials for biomedical applications is important for creating
efficient therapeutic devices for magnetic hyperthermia to ensure positive results for
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patients. This same library can be used for fundamental research in understanding how
particles interactions (determined by molecular weight, magnetic core size, concentration
and surface chemistry) affect the SAR in an alternating magnetic field.190
The surface functionality of an alkyne on the magnetic nanoparticles also
facilitates crosslinking the particles using “click chemistry” to form clusters of magnetic
nanoparticles, Figure 6.4, which can offer improved magnetic properties. Using a short
chain molecule with an azide on both sides can be used to link the alkyne surface of the
magnetic nanoparticles together. The controlled clustering of the particles will create a
different anisotropy and interaction that will increase the saturation magnetization of the
particles.191 This approach to clustering magnetic nanoparticles will still have an alkyne
functional surface that can be modified further with targeting and imaging moieties using
“click chemistry.”

Figure 6.4. Schematic of clustered nanoparticles via “click chemistry” using a bis-azide
to link the alkyne surface of the magnetic nanoparticles.
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Using targeting agents for delivering the magnetic nanoparticles to infected areas
is very useful for increasing the efficiency of the treatment because of the increase
concentration at the site to initiate endocytosis.192 Unfortunately, this usually only
happens at the surface where the receptors are over-expressed and are not internalized,
and will require multiple treatments to completely remove tumor. One way to facilitate
the internalization of nanoparticles into infected cells is by combining different charges
and targeting moieties onto the surface,193 represented by Figure 6.5. Different functional
groups that can provide a variety of surface chemistry when dispersed in water (i.e.
amine, carboxylic acid, thiol, alcohol, and methyl groups) can be used for studying how
different surfaces can affect the biodistribution and cell uptake of nanoparticles in the
human body. Their location and concentration can be visualized and quantified using
fluorescent magnetic resonance imaging.
NH2
NH2

NH2
H 2N

NH2

Figure 6.5. Magnetic nanoparticle displaying a surface with a combination of alkyne for
functionalization with a targeting or fluorescent moiety and amines for aiding in
internalization.
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The materials designed and synthesized in this work have great potential for
fundamental research on materials used for magnetic hyperthermia that is necessary if
they are to be a viable alternative to current treatments on the market. A water-dispersible
nanoparticle that can be easily functionalized for a variety of applications, which has
been presented in Chapter 5, is very important for biological research but material
development must continue to optimize the number of steps to synthesize these
specialized materials for them to be a realistic option.
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CHAPTER 7. CONCLUSIONS
This work has presented the synthesis of a variety of heterobifunctional PEOs that
were prepared by the anionic ring opening polymerization of ethylene oxide and end
group modification. The variety of polymers synthesized in Chapter 1 were the
motivation to develop a specialized heterobifunctional PEO that can be utilized for
building a water-soluble magnetic nanoparticle complex with functional scaffolding for
use in an assortment of biological applications. To confirm the versatility of the
functional scaffolding, it was modified with a variety of fluorescent dyes that could be
easily observed using photoluminescence. The particles were also modified with two
dyes simultaneously to demonstrate the multifunctional capabilities that can be very
useful for targeted therapeutics and diagnostics.
To improve the biological stability of the magnetic nanoparticles that is needed
for increased circulation and efficient drug delivery, a specialized heterobifunctional PEO
and nitroDOPA was attached to a PAA backbone to increase the number of anchoring
groups that can interact with the iron oxide surface. The increase in biological stability of
the multi-anchored nanoparticles compared to mono-anchored nanoparticles was
demonstrated by submitting them to protein and ionic rich environments at elevated
temperatures while measuring the change in hydrodynamic diameter.
The ease of customization of these particles was attractive to other research areas
outside of magnetic hyperthermia of cancer. They were modified with: a tri-saccharide to
target and cluster E. coli K99; a fluorescent dye to image them in biofilms; and a
radiotracer that can be used as in vivo biomedical diagnostic probes. These polymer-
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magnetic nanoparticle complexes show great potential for offering an alternative to
current theranostics and fundamental magnetic hypothermia research.
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